WO2000070080A1 - Focusing of microparticles in microfluidic systems - Google Patents
Focusing of microparticles in microfluidic systems Download PDFInfo
- Publication number
- WO2000070080A1 WO2000070080A1 PCT/US2000/013294 US0013294W WO0070080A1 WO 2000070080 A1 WO2000070080 A1 WO 2000070080A1 US 0013294 W US0013294 W US 0013294W WO 0070080 A1 WO0070080 A1 WO 0070080A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- microchannel
- fluid
- microchannels
- flow
- cells
- Prior art date
Links
- 239000011859 microparticle Substances 0.000 title description 11
- 239000002245 particle Substances 0.000 claims abstract description 188
- 238000000034 method Methods 0.000 claims abstract description 114
- 238000003556 assay Methods 0.000 claims abstract description 55
- 239000012530 fluid Substances 0.000 claims description 187
- 238000001514 detection method Methods 0.000 claims description 47
- 238000010438 heat treatment Methods 0.000 claims description 44
- 238000012360 testing method Methods 0.000 claims description 42
- 239000011325 microbead Substances 0.000 claims description 32
- 230000006907 apoptotic process Effects 0.000 claims description 30
- 239000000463 material Substances 0.000 claims description 27
- 238000000926 separation method Methods 0.000 claims description 24
- 238000011144 upstream manufacturing Methods 0.000 claims description 15
- 239000003085 diluting agent Substances 0.000 claims description 14
- 238000005406 washing Methods 0.000 claims description 12
- 238000012288 TUNEL assay Methods 0.000 claims description 11
- 102000004121 Annexin A5 Human genes 0.000 claims description 9
- 108090000672 Annexin A5 Proteins 0.000 claims description 9
- 230000005284 excitation Effects 0.000 claims description 7
- 239000003153 chemical reaction reagent Substances 0.000 claims description 6
- 230000003213 activating effect Effects 0.000 claims description 5
- 239000002773 nucleotide Substances 0.000 claims description 5
- 125000003729 nucleotide group Chemical group 0.000 claims description 5
- 230000004044 response Effects 0.000 claims description 5
- 229960002685 biotin Drugs 0.000 claims description 4
- 239000011616 biotin Substances 0.000 claims description 4
- 230000001939 inductive effect Effects 0.000 claims description 4
- 230000001105 regulatory effect Effects 0.000 claims description 4
- BQRGNLJZBFXNCZ-UHFFFAOYSA-N calcein am Chemical compound O1C(=O)C2=CC=CC=C2C21C1=CC(CN(CC(=O)OCOC(C)=O)CC(=O)OCOC(C)=O)=C(OC(C)=O)C=C1OC1=C2C=C(CN(CC(=O)OCOC(C)=O)CC(=O)OCOC(=O)C)C(OC(C)=O)=C1 BQRGNLJZBFXNCZ-UHFFFAOYSA-N 0.000 claims description 3
- 108090000992 Transferases Proteins 0.000 claims description 2
- 102000004357 Transferases Human genes 0.000 claims description 2
- OALHHIHQOFIMEF-UHFFFAOYSA-N 3',6'-dihydroxy-2',4',5',7'-tetraiodo-3h-spiro[2-benzofuran-1,9'-xanthene]-3-one Chemical compound O1C(=O)C2=CC=CC=C2C21C1=CC(I)=C(O)C(I)=C1OC1=C(I)C(O)=C(I)C=C21 OALHHIHQOFIMEF-UHFFFAOYSA-N 0.000 claims 1
- 238000005070 sampling Methods 0.000 claims 1
- 210000004027 cell Anatomy 0.000 description 263
- 150000001875 compounds Chemical class 0.000 description 50
- 230000006870 function Effects 0.000 description 37
- 239000000758 substrate Substances 0.000 description 31
- 238000009739 binding Methods 0.000 description 27
- 230000027455 binding Effects 0.000 description 26
- 239000000872 buffer Substances 0.000 description 25
- 230000001640 apoptogenic effect Effects 0.000 description 24
- 239000006285 cell suspension Substances 0.000 description 24
- 239000000975 dye Substances 0.000 description 21
- 230000014509 gene expression Effects 0.000 description 21
- 108090000623 proteins and genes Proteins 0.000 description 20
- 238000004458 analytical method Methods 0.000 description 16
- 230000000694 effects Effects 0.000 description 16
- 239000000523 sample Substances 0.000 description 16
- 238000012216 screening Methods 0.000 description 16
- 239000000725 suspension Substances 0.000 description 16
- 230000032258 transport Effects 0.000 description 16
- 238000002372 labelling Methods 0.000 description 13
- 239000003446 ligand Substances 0.000 description 13
- -1 cells Substances 0.000 description 12
- 230000003287 optical effect Effects 0.000 description 12
- 239000011324 bead Substances 0.000 description 11
- 239000000047 product Substances 0.000 description 11
- 230000001413 cellular effect Effects 0.000 description 10
- 230000003834 intracellular effect Effects 0.000 description 10
- 102000004169 proteins and genes Human genes 0.000 description 10
- 238000005096 rolling process Methods 0.000 description 10
- 108020004414 DNA Proteins 0.000 description 9
- 230000003915 cell function Effects 0.000 description 9
- 239000000499 gel Substances 0.000 description 9
- 230000007246 mechanism Effects 0.000 description 9
- 239000012528 membrane Substances 0.000 description 9
- 102000005962 receptors Human genes 0.000 description 9
- 108020003175 receptors Proteins 0.000 description 9
- 230000035899 viability Effects 0.000 description 9
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 8
- GNBHRKFJIUUOQI-UHFFFAOYSA-N fluorescein Chemical compound O1C(=O)C2=CC=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 GNBHRKFJIUUOQI-UHFFFAOYSA-N 0.000 description 8
- 239000011521 glass Substances 0.000 description 8
- 238000009652 hydrodynamic focusing Methods 0.000 description 8
- 102000039446 nucleic acids Human genes 0.000 description 8
- 108020004707 nucleic acids Proteins 0.000 description 8
- 150000007523 nucleic acids Chemical class 0.000 description 8
- 239000007787 solid Substances 0.000 description 8
- 238000000423 cell based assay Methods 0.000 description 7
- 230000003833 cell viability Effects 0.000 description 7
- 238000004891 communication Methods 0.000 description 7
- 238000002474 experimental method Methods 0.000 description 7
- 238000000684 flow cytometry Methods 0.000 description 7
- 230000002706 hydrostatic effect Effects 0.000 description 7
- 238000011534 incubation Methods 0.000 description 7
- 108010008286 DNA nucleotidylexotransferase Proteins 0.000 description 6
- 102100033215 DNA nucleotidylexotransferase Human genes 0.000 description 6
- 230000001965 increasing effect Effects 0.000 description 6
- 230000033001 locomotion Effects 0.000 description 6
- 239000003068 molecular probe Substances 0.000 description 6
- 239000004033 plastic Substances 0.000 description 6
- 229920003023 plastic Polymers 0.000 description 6
- JKMHFZQWWAIEOD-UHFFFAOYSA-N 2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid Chemical compound OCC[NH+]1CCN(CCS([O-])(=O)=O)CC1 JKMHFZQWWAIEOD-UHFFFAOYSA-N 0.000 description 5
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 5
- 102000004190 Enzymes Human genes 0.000 description 5
- 108090000790 Enzymes Proteins 0.000 description 5
- 239000007995 HEPES buffer Substances 0.000 description 5
- 239000011575 calcium Substances 0.000 description 5
- 229910052791 calcium Inorganic materials 0.000 description 5
- 238000002347 injection Methods 0.000 description 5
- 239000007924 injection Substances 0.000 description 5
- 150000002500 ions Chemical class 0.000 description 5
- 241000894007 species Species 0.000 description 5
- 230000005778 DNA damage Effects 0.000 description 4
- 231100000277 DNA damage Toxicity 0.000 description 4
- 208000014197 Fetal anticonvulsant syndrome Diseases 0.000 description 4
- OZLGRUXZXMRXGP-UHFFFAOYSA-N Fluo-3 Chemical compound CC1=CC=C(N(CC(O)=O)CC(O)=O)C(OCCOC=2C(=CC=C(C=2)C2=C3C=C(Cl)C(=O)C=C3OC3=CC(O)=C(Cl)C=C32)N(CC(O)=O)CC(O)=O)=C1 OZLGRUXZXMRXGP-UHFFFAOYSA-N 0.000 description 4
- 239000002202 Polyethylene glycol Substances 0.000 description 4
- 238000006243 chemical reaction Methods 0.000 description 4
- 238000000576 coating method Methods 0.000 description 4
- 230000001276 controlling effect Effects 0.000 description 4
- 229920001577 copolymer Polymers 0.000 description 4
- 230000007423 decrease Effects 0.000 description 4
- 238000009826 distribution Methods 0.000 description 4
- 239000012636 effector Substances 0.000 description 4
- 238000001943 fluorescence-activated cell sorting Methods 0.000 description 4
- 230000003993 interaction Effects 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- 229920001223 polyethylene glycol Polymers 0.000 description 4
- 238000007423 screening assay Methods 0.000 description 4
- 230000001953 sensory effect Effects 0.000 description 4
- 239000011534 wash buffer Substances 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- 108020004774 Alkaline Phosphatase Proteins 0.000 description 3
- 102000002260 Alkaline Phosphatase Human genes 0.000 description 3
- 108090000371 Esterases Proteins 0.000 description 3
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 3
- 206010028980 Neoplasm Diseases 0.000 description 3
- 230000004913 activation Effects 0.000 description 3
- 238000003782 apoptosis assay Methods 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 230000008512 biological response Effects 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 201000011510 cancer Diseases 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- 238000013461 design Methods 0.000 description 3
- 238000010195 expression analysis Methods 0.000 description 3
- 238000002866 fluorescence resonance energy transfer Methods 0.000 description 3
- 238000013537 high throughput screening Methods 0.000 description 3
- 238000012188 high-throughput screening assay Methods 0.000 description 3
- 238000005286 illumination Methods 0.000 description 3
- 238000007373 indentation Methods 0.000 description 3
- 230000001404 mediated effect Effects 0.000 description 3
- 230000037361 pathway Effects 0.000 description 3
- 229920003229 poly(methyl methacrylate) Polymers 0.000 description 3
- 239000004926 polymethyl methacrylate Substances 0.000 description 3
- 239000002243 precursor Substances 0.000 description 3
- 108090000765 processed proteins & peptides Proteins 0.000 description 3
- 102000004196 processed proteins & peptides Human genes 0.000 description 3
- 230000005522 programmed cell death Effects 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 238000004381 surface treatment Methods 0.000 description 3
- 210000001519 tissue Anatomy 0.000 description 3
- 238000012546 transfer Methods 0.000 description 3
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
- XIAYFENBYCWHGY-UHFFFAOYSA-N 2-[2,7-bis[[bis(carboxymethyl)amino]methyl]-3-hydroxy-6-oxoxanthen-9-yl]benzoic acid Chemical compound C=12C=C(CN(CC(O)=O)CC(O)=O)C(=O)C=C2OC=2C=C(O)C(CN(CC(O)=O)CC(=O)O)=CC=2C=1C1=CC=CC=C1C(O)=O XIAYFENBYCWHGY-UHFFFAOYSA-N 0.000 description 2
- SMKBSSHVLHIPLU-UHFFFAOYSA-N 3-acridin-10-ium-10-ylpropane-1-sulfonate Chemical compound C1=CC=C2[N+](CCCS(=O)(=O)[O-])=C(C=CC=C3)C3=CC2=C1 SMKBSSHVLHIPLU-UHFFFAOYSA-N 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 2
- 229920002307 Dextran Polymers 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 108010043121 Green Fluorescent Proteins Proteins 0.000 description 2
- 102000004144 Green Fluorescent Proteins Human genes 0.000 description 2
- 239000004793 Polystyrene Substances 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 230000001464 adherent effect Effects 0.000 description 2
- 230000004075 alteration Effects 0.000 description 2
- 239000000427 antigen Substances 0.000 description 2
- 230000000890 antigenic effect Effects 0.000 description 2
- 102000036639 antigens Human genes 0.000 description 2
- 108091007433 antigens Proteins 0.000 description 2
- 208000034615 apoptosis-related disease Diseases 0.000 description 2
- 230000003115 biocidal effect Effects 0.000 description 2
- 230000033228 biological regulation Effects 0.000 description 2
- 210000004204 blood vessel Anatomy 0.000 description 2
- DEGAKNSWVGKMLS-UHFFFAOYSA-N calcein Chemical compound O1C(=O)C2=CC=CC=C2C21C1=CC(CN(CC(O)=O)CC(O)=O)=C(O)C=C1OC1=C2C=C(CN(CC(O)=O)CC(=O)O)C(O)=C1 DEGAKNSWVGKMLS-UHFFFAOYSA-N 0.000 description 2
- 230000030833 cell death Effects 0.000 description 2
- 210000000170 cell membrane Anatomy 0.000 description 2
- 230000004663 cell proliferation Effects 0.000 description 2
- 230000004656 cell transport Effects 0.000 description 2
- 238000003570 cell viability assay Methods 0.000 description 2
- 239000001913 cellulose Substances 0.000 description 2
- 229920002678 cellulose Polymers 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 239000011248 coating agent Substances 0.000 description 2
- 238000007405 data analysis Methods 0.000 description 2
- 239000004205 dimethyl polysiloxane Substances 0.000 description 2
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 2
- BFMYDTVEBKDAKJ-UHFFFAOYSA-L disodium;(2',7'-dibromo-3',6'-dioxido-3-oxospiro[2-benzofuran-1,9'-xanthene]-4'-yl)mercury;hydrate Chemical compound O.[Na+].[Na+].O1C(=O)C2=CC=CC=C2C21C1=CC(Br)=C([O-])C([Hg])=C1OC1=C2C=C(Br)C([O-])=C1 BFMYDTVEBKDAKJ-UHFFFAOYSA-L 0.000 description 2
- 230000005520 electrodynamics Effects 0.000 description 2
- 238000004049 embossing Methods 0.000 description 2
- 239000000835 fiber Substances 0.000 description 2
- 230000004907 flux Effects 0.000 description 2
- 239000012634 fragment Substances 0.000 description 2
- 238000013467 fragmentation Methods 0.000 description 2
- 238000006062 fragmentation reaction Methods 0.000 description 2
- 239000005350 fused silica glass Substances 0.000 description 2
- 230000002068 genetic effect Effects 0.000 description 2
- 239000005090 green fluorescent protein Substances 0.000 description 2
- 238000000338 in vitro Methods 0.000 description 2
- 238000001746 injection moulding Methods 0.000 description 2
- 238000009830 intercalation Methods 0.000 description 2
- 230000008611 intercellular interaction Effects 0.000 description 2
- 210000004962 mammalian cell Anatomy 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 238000007899 nucleic acid hybridization Methods 0.000 description 2
- 229960002378 oftasceine Drugs 0.000 description 2
- 239000007793 ph indicator Substances 0.000 description 2
- 239000002953 phosphate buffered saline Substances 0.000 description 2
- 230000035790 physiological processes and functions Effects 0.000 description 2
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 2
- 229920002401 polyacrylamide Polymers 0.000 description 2
- 239000004417 polycarbonate Substances 0.000 description 2
- 229920000515 polycarbonate Polymers 0.000 description 2
- 108091033319 polynucleotide Proteins 0.000 description 2
- 102000040430 polynucleotide Human genes 0.000 description 2
- 239000002157 polynucleotide Substances 0.000 description 2
- 229920001184 polypeptide Polymers 0.000 description 2
- 229920002223 polystyrene Polymers 0.000 description 2
- 239000004810 polytetrafluoroethylene Substances 0.000 description 2
- 229920001343 polytetrafluoroethylene Polymers 0.000 description 2
- XJMOSONTPMZWPB-UHFFFAOYSA-M propidium iodide Chemical compound [I-].[I-].C12=CC(N)=CC=C2C2=CC=C(N)C=C2[N+](CCC[N+](C)(CC)CC)=C1C1=CC=CC=C1 XJMOSONTPMZWPB-UHFFFAOYSA-M 0.000 description 2
- 238000000159 protein binding assay Methods 0.000 description 2
- 239000010453 quartz Substances 0.000 description 2
- 239000011541 reaction mixture Substances 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 239000010703 silicon Substances 0.000 description 2
- 229910052710 silicon Inorganic materials 0.000 description 2
- 238000004513 sizing Methods 0.000 description 2
- 238000001179 sorption measurement Methods 0.000 description 2
- 230000002459 sustained effect Effects 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- 230000007704 transition Effects 0.000 description 2
- CHADEQDQBURGHL-UHFFFAOYSA-N (6'-acetyloxy-3-oxospiro[2-benzofuran-1,9'-xanthene]-3'-yl) acetate Chemical compound O1C(=O)C2=CC=CC=C2C21C1=CC=C(OC(C)=O)C=C1OC1=CC(OC(=O)C)=CC=C21 CHADEQDQBURGHL-UHFFFAOYSA-N 0.000 description 1
- ZVDGOJFPFMINBM-UHFFFAOYSA-N 3-(6-methoxyquinolin-1-ium-1-yl)propane-1-sulfonate Chemical compound [O-]S(=O)(=O)CCC[N+]1=CC=CC2=CC(OC)=CC=C21 ZVDGOJFPFMINBM-UHFFFAOYSA-N 0.000 description 1
- YOQMJMHTHWYNIO-UHFFFAOYSA-N 4-[6-[16-[2-(2,4-dicarboxyphenyl)-5-methoxy-1-benzofuran-6-yl]-1,4,10,13-tetraoxa-7,16-diazacyclooctadec-7-yl]-5-methoxy-1-benzofuran-2-yl]benzene-1,3-dicarboxylic acid Chemical compound COC1=CC=2C=C(C=3C(=CC(=CC=3)C(O)=O)C(O)=O)OC=2C=C1N(CCOCCOCC1)CCOCCOCCN1C(C(=CC=1C=2)OC)=CC=1OC=2C1=CC=C(C(O)=O)C=C1C(O)=O YOQMJMHTHWYNIO-UHFFFAOYSA-N 0.000 description 1
- 229920000936 Agarose Polymers 0.000 description 1
- 206010001497 Agitation Diseases 0.000 description 1
- 208000024827 Alzheimer disease Diseases 0.000 description 1
- JBRZTFJDHDCESZ-UHFFFAOYSA-N AsGa Chemical compound [As]#[Ga] JBRZTFJDHDCESZ-UHFFFAOYSA-N 0.000 description 1
- 241000182988 Assa Species 0.000 description 1
- FTEDXVNDVHYDQW-UHFFFAOYSA-N BAPTA Chemical compound OC(=O)CN(CC(O)=O)C1=CC=CC=C1OCCOC1=CC=CC=C1N(CC(O)=O)CC(O)=O FTEDXVNDVHYDQW-UHFFFAOYSA-N 0.000 description 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- 102000016289 Cell Adhesion Molecules Human genes 0.000 description 1
- 108010067225 Cell Adhesion Molecules Proteins 0.000 description 1
- 102000000844 Cell Surface Receptors Human genes 0.000 description 1
- 108010001857 Cell Surface Receptors Proteins 0.000 description 1
- 108091026890 Coding region Proteins 0.000 description 1
- AHCYMLUZIRLXAA-SHYZEUOFSA-N Deoxyuridine 5'-triphosphate Chemical compound O1[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)C[C@@H]1N1C(=O)NC(=O)C=C1 AHCYMLUZIRLXAA-SHYZEUOFSA-N 0.000 description 1
- 206010013710 Drug interaction Diseases 0.000 description 1
- 206010059866 Drug resistance Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 108010067770 Endopeptidase K Proteins 0.000 description 1
- QTANTQQOYSUMLC-UHFFFAOYSA-O Ethidium cation Chemical compound C12=CC(N)=CC=C2C2=CC=C(N)C=C2[N+](CC)=C1C1=CC=CC=C1 QTANTQQOYSUMLC-UHFFFAOYSA-O 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 108091006027 G proteins Proteins 0.000 description 1
- 102000003688 G-Protein-Coupled Receptors Human genes 0.000 description 1
- 108090000045 G-Protein-Coupled Receptors Proteins 0.000 description 1
- 102000030782 GTP binding Human genes 0.000 description 1
- 108091000058 GTP-Binding Proteins 0.000 description 1
- 229910001218 Gallium arsenide Inorganic materials 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 102000004310 Ion Channels Human genes 0.000 description 1
- 108060001084 Luciferase Proteins 0.000 description 1
- 239000005089 Luciferase Substances 0.000 description 1
- 208000015439 Lysosomal storage disease Diseases 0.000 description 1
- 102000018697 Membrane Proteins Human genes 0.000 description 1
- 108010052285 Membrane Proteins Proteins 0.000 description 1
- 206010027476 Metastases Diseases 0.000 description 1
- 239000000020 Nitrocellulose Substances 0.000 description 1
- 108091093105 Nuclear DNA Proteins 0.000 description 1
- 239000004677 Nylon Substances 0.000 description 1
- 108700020796 Oncogene Proteins 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 239000004743 Polypropylene Substances 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 1
- 108020004511 Recombinant DNA Proteins 0.000 description 1
- 102000003800 Selectins Human genes 0.000 description 1
- 108090000184 Selectins Proteins 0.000 description 1
- 229920005654 Sephadex Polymers 0.000 description 1
- 239000012507 Sephadex™ Substances 0.000 description 1
- 229920002684 Sepharose Polymers 0.000 description 1
- 108010090804 Streptavidin Proteins 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- 210000001744 T-lymphocyte Anatomy 0.000 description 1
- 238000005299 abrasion Methods 0.000 description 1
- NTECHUXHORNEGZ-UHFFFAOYSA-N acetyloxymethyl 3',6'-bis(acetyloxymethoxy)-2',7'-bis[3-(acetyloxymethoxy)-3-oxopropyl]-3-oxospiro[2-benzofuran-1,9'-xanthene]-5-carboxylate Chemical compound O1C(=O)C2=CC(C(=O)OCOC(C)=O)=CC=C2C21C1=CC(CCC(=O)OCOC(C)=O)=C(OCOC(C)=O)C=C1OC1=C2C=C(CCC(=O)OCOC(=O)C)C(OCOC(C)=O)=C1 NTECHUXHORNEGZ-UHFFFAOYSA-N 0.000 description 1
- 239000000980 acid dye Substances 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- 238000004220 aggregation Methods 0.000 description 1
- 210000004102 animal cell Anatomy 0.000 description 1
- 230000000845 anti-microbial effect Effects 0.000 description 1
- 210000003719 b-lymphocyte Anatomy 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 108010005774 beta-Galactosidase Proteins 0.000 description 1
- 102000005936 beta-Galactosidase Human genes 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 230000008827 biological function Effects 0.000 description 1
- 230000031018 biological processes and functions Effects 0.000 description 1
- 235000020958 biotin Nutrition 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
- 230000020411 cell activation Effects 0.000 description 1
- 230000021164 cell adhesion Effects 0.000 description 1
- 230000024245 cell differentiation Effects 0.000 description 1
- 230000001427 coherent effect Effects 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 230000002508 compound effect Effects 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- MROCJMGDEKINLD-UHFFFAOYSA-N dichlorosilane Chemical compound Cl[SiH2]Cl MROCJMGDEKINLD-UHFFFAOYSA-N 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- 125000000118 dimethyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 238000007598 dipping method Methods 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 238000006073 displacement reaction Methods 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 229940000406 drug candidate Drugs 0.000 description 1
- 230000009977 dual effect Effects 0.000 description 1
- 238000005370 electroosmosis Methods 0.000 description 1
- 230000003511 endothelial effect Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 239000003623 enhancer Substances 0.000 description 1
- 239000006167 equilibration buffer Substances 0.000 description 1
- ZMMJGEGLRURXTF-UHFFFAOYSA-N ethidium bromide Chemical compound [Br-].C12=CC(N)=CC=C2C2=CC=C(N)C=C2[N+](CC)=C1C1=CC=CC=C1 ZMMJGEGLRURXTF-UHFFFAOYSA-N 0.000 description 1
- 229960005542 ethidium bromide Drugs 0.000 description 1
- GTSMOYLSFUBTMV-UHFFFAOYSA-N ethidium homodimer Chemical compound [H+].[H+].[Cl-].[Cl-].[Cl-].[Cl-].C12=CC(N)=CC=C2C2=CC=C(N)C=C2C(C)=[N+]1CCCNCCNCCC[N+](C1=CC(N)=CC=C1C1=CC=C(N)C=C11)=C1C1=CC=CC=C1 GTSMOYLSFUBTMV-UHFFFAOYSA-N 0.000 description 1
- HEYSKURSHFYAMR-UHFFFAOYSA-N ethyl 2-(6-methoxyquinolin-1-ium-1-yl)acetate Chemical compound COC1=CC=C2[N+](CC(=O)OCC)=CC=CC2=C1 HEYSKURSHFYAMR-UHFFFAOYSA-N 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 230000004720 fertilization Effects 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- YFHXZQPUBCBNIP-UHFFFAOYSA-N fura-2 Chemical compound CC1=CC=C(N(CC(O)=O)CC(O)=O)C(OCCOC=2C(=CC=3OC(=CC=3C=2)C=2OC(=CN=2)C(O)=O)N(CC(O)=O)CC(O)=O)=C1 YFHXZQPUBCBNIP-UHFFFAOYSA-N 0.000 description 1
- 230000004927 fusion Effects 0.000 description 1
- 238000003633 gene expression assay Methods 0.000 description 1
- 230000005484 gravity Effects 0.000 description 1
- 239000003102 growth factor Substances 0.000 description 1
- 230000003054 hormonal effect Effects 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 238000003384 imaging method Methods 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 229910052738 indium Inorganic materials 0.000 description 1
- PNDZEEPOYCVIIY-UHFFFAOYSA-N indo-1 Chemical compound CC1=CC=C(N(CC(O)=O)CC(O)=O)C(OCCOC=2C(=CC=C(C=2)C=2N=C3[CH]C(=CC=C3C=2)C(O)=O)N(CC(O)=O)CC(O)=O)=C1 PNDZEEPOYCVIIY-UHFFFAOYSA-N 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 102000006495 integrins Human genes 0.000 description 1
- 108010044426 integrins Proteins 0.000 description 1
- 239000003456 ion exchange resin Substances 0.000 description 1
- 230000010220 ion permeability Effects 0.000 description 1
- 230000037427 ion transport Effects 0.000 description 1
- 229920003303 ion-exchange polymer Polymers 0.000 description 1
- 238000000608 laser ablation Methods 0.000 description 1
- 150000002611 lead compounds Chemical class 0.000 description 1
- 210000000265 leukocyte Anatomy 0.000 description 1
- 239000002502 liposome Substances 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 229920002521 macromolecule Polymers 0.000 description 1
- 239000011976 maleic acid Substances 0.000 description 1
- 230000036210 malignancy Effects 0.000 description 1
- 230000000873 masking effect Effects 0.000 description 1
- QSHDDOUJBYECFT-UHFFFAOYSA-N mercury Chemical compound [Hg] QSHDDOUJBYECFT-UHFFFAOYSA-N 0.000 description 1
- 229910052753 mercury Inorganic materials 0.000 description 1
- 230000009401 metastasis Effects 0.000 description 1
- 230000003278 mimic effect Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 230000000877 morphologic effect Effects 0.000 description 1
- 230000004660 morphological change Effects 0.000 description 1
- 238000000465 moulding Methods 0.000 description 1
- 229920001220 nitrocellulos Polymers 0.000 description 1
- 229920001778 nylon Polymers 0.000 description 1
- 210000003463 organelle Anatomy 0.000 description 1
- 230000010355 oscillation Effects 0.000 description 1
- 238000001139 pH measurement Methods 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 238000004091 panning Methods 0.000 description 1
- 239000000123 paper Substances 0.000 description 1
- 238000000206 photolithography Methods 0.000 description 1
- 239000002985 plastic film Substances 0.000 description 1
- 229920006255 plastic film Polymers 0.000 description 1
- 229920002492 poly(sulfone) Polymers 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 229920000306 polymethylpentene Polymers 0.000 description 1
- 239000011116 polymethylpentene Substances 0.000 description 1
- 229920005862 polyol Polymers 0.000 description 1
- 150000003077 polyols Chemical class 0.000 description 1
- 229920001155 polypropylene Polymers 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 230000003334 potential effect Effects 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 230000007398 protein translocation Effects 0.000 description 1
- KXXXUIKPSVVSAW-UHFFFAOYSA-K pyranine Chemical compound [Na+].[Na+].[Na+].C1=C2C(O)=CC(S([O-])(=O)=O)=C(C=C3)C2=C2C3=C(S([O-])(=O)=O)C=C(S([O-])(=O)=O)C2=C1 KXXXUIKPSVVSAW-UHFFFAOYSA-K 0.000 description 1
- 238000011002 quantification Methods 0.000 description 1
- 102000016914 ras Proteins Human genes 0.000 description 1
- 230000020988 regulation of intracellular pH Effects 0.000 description 1
- 238000012552 review Methods 0.000 description 1
- 239000012266 salt solution Substances 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 238000010517 secondary reaction Methods 0.000 description 1
- 239000004065 semiconductor Substances 0.000 description 1
- DYPYMMHZGRPOCK-UHFFFAOYSA-N seminaphtharhodafluor Chemical compound O1C(=O)C2=CC=CC=C2C21C(C=CC=1C3=CC=C(O)C=1)=C3OC1=CC(N)=CC=C21 DYPYMMHZGRPOCK-UHFFFAOYSA-N 0.000 description 1
- 238000012163 sequencing technique Methods 0.000 description 1
- 238000002444 silanisation Methods 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 229910052814 silicon oxide Inorganic materials 0.000 description 1
- 150000003384 small molecules Chemical class 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- UGJCNRLBGKEGEH-UHFFFAOYSA-N sodium-binding benzofuran isophthalate Chemical compound COC1=CC=2C=C(C=3C(=CC(=CC=3)C(O)=O)C(O)=O)OC=2C=C1N(CCOCC1)CCOCCOCCN1C(C(=CC=1C=2)OC)=CC=1OC=2C1=CC=C(C(O)=O)C=C1C(O)=O UGJCNRLBGKEGEH-UHFFFAOYSA-N 0.000 description 1
- 239000007790 solid phase Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 230000009870 specific binding Effects 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 238000009987 spinning Methods 0.000 description 1
- 238000010186 staining Methods 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- ANRHNWWPFJCPAZ-UHFFFAOYSA-M thionine Chemical compound [Cl-].C1=CC(N)=CC2=[S+]C3=CC(N)=CC=C3N=C21 ANRHNWWPFJCPAZ-UHFFFAOYSA-M 0.000 description 1
- 231100000041 toxicology testing Toxicity 0.000 description 1
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 1
- 238000013518 transcription Methods 0.000 description 1
- 230000035897 transcription Effects 0.000 description 1
- 238000001890 transfection Methods 0.000 description 1
- 238000011282 treatment Methods 0.000 description 1
- 230000001960 triggered effect Effects 0.000 description 1
- 230000007306 turnover Effects 0.000 description 1
- 238000012036 ultra high throughput screening Methods 0.000 description 1
- 231100000747 viability assay Toxicity 0.000 description 1
- 238000003026 viability measurement method Methods 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
- 238000003466 welding Methods 0.000 description 1
- 238000003631 wet chemical etching Methods 0.000 description 1
- 230000029663 wound healing Effects 0.000 description 1
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01F—MIXING, e.g. DISSOLVING, EMULSIFYING OR DISPERSING
- B01F33/00—Other mixers; Mixing plants; Combinations of mixers
- B01F33/30—Micromixers
- B01F33/301—Micromixers using specific means for arranging the streams to be mixed, e.g. channel geometries or dispositions
- B01F33/3011—Micromixers using specific means for arranging the streams to be mixed, e.g. channel geometries or dispositions using a sheathing stream of a fluid surrounding a central stream of a different fluid, e.g. for reducing the cross-section of the central stream or to produce droplets from the central stream
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J19/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J19/0093—Microreactors, e.g. miniaturised or microfabricated reactors
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L3/00—Containers or dishes for laboratory use, e.g. laboratory glassware; Droppers
- B01L3/50—Containers for the purpose of retaining a material to be analysed, e.g. test tubes
- B01L3/502—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures
- B01L3/5027—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures by integrated microfluidic structures, i.e. dimensions of channels and chambers are such that surface tension forces are important, e.g. lab-on-a-chip
- B01L3/502761—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures by integrated microfluidic structures, i.e. dimensions of channels and chambers are such that surface tension forces are important, e.g. lab-on-a-chip specially adapted for handling suspended solids or molecules independently from the bulk fluid flow, e.g. for trapping or sorting beads, for physically stretching molecules
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L3/00—Containers or dishes for laboratory use, e.g. laboratory glassware; Droppers
- B01L3/50—Containers for the purpose of retaining a material to be analysed, e.g. test tubes
- B01L3/502—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures
- B01L3/5027—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures by integrated microfluidic structures, i.e. dimensions of channels and chambers are such that surface tension forces are important, e.g. lab-on-a-chip
- B01L3/502769—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures by integrated microfluidic structures, i.e. dimensions of channels and chambers are such that surface tension forces are important, e.g. lab-on-a-chip characterised by multiphase flow arrangements
- B01L3/502776—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures by integrated microfluidic structures, i.e. dimensions of channels and chambers are such that surface tension forces are important, e.g. lab-on-a-chip characterised by multiphase flow arrangements specially adapted for focusing or laminating flows
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N15/00—Investigating characteristics of particles; Investigating permeability, pore-volume or surface-area of porous materials
- G01N15/10—Investigating individual particles
- G01N15/14—Optical investigation techniques, e.g. flow cytometry
- G01N15/1404—Handling flow, e.g. hydrodynamic focusing
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N27/00—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means
- G01N27/26—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means by investigating electrochemical variables; by using electrolysis or electrophoresis
- G01N27/416—Systems
- G01N27/447—Systems using electrophoresis
- G01N27/44704—Details; Accessories
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N27/00—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means
- G01N27/26—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means by investigating electrochemical variables; by using electrolysis or electrophoresis
- G01N27/416—Systems
- G01N27/447—Systems using electrophoresis
- G01N27/44756—Apparatus specially adapted therefor
- G01N27/44791—Microapparatus
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J2219/00781—Aspects relating to microreactors
- B01J2219/00889—Mixing
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2219/00—Chemical, physical or physico-chemical processes in general; Their relevant apparatus
- B01J2219/00781—Aspects relating to microreactors
- B01J2219/00891—Feeding or evacuation
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L2200/00—Solutions for specific problems relating to chemical or physical laboratory apparatus
- B01L2200/06—Fluid handling related problems
- B01L2200/0636—Focussing flows, e.g. to laminate flows
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L2200/00—Solutions for specific problems relating to chemical or physical laboratory apparatus
- B01L2200/06—Fluid handling related problems
- B01L2200/0647—Handling flowable solids, e.g. microscopic beads, cells, particles
- B01L2200/0652—Sorting or classification of particles or molecules
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L2400/00—Moving or stopping fluids
- B01L2400/04—Moving fluids with specific forces or mechanical means
- B01L2400/0403—Moving fluids with specific forces or mechanical means specific forces
- B01L2400/0406—Moving fluids with specific forces or mechanical means specific forces capillary forces
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L2400/00—Moving or stopping fluids
- B01L2400/04—Moving fluids with specific forces or mechanical means
- B01L2400/0475—Moving fluids with specific forces or mechanical means specific mechanical means and fluid pressure
- B01L2400/0487—Moving fluids with specific forces or mechanical means specific mechanical means and fluid pressure fluid pressure, pneumatics
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N15/00—Investigating characteristics of particles; Investigating permeability, pore-volume or surface-area of porous materials
- G01N15/10—Investigating individual particles
- G01N15/14—Optical investigation techniques, e.g. flow cytometry
- G01N15/1404—Handling flow, e.g. hydrodynamic focusing
- G01N15/1409—Handling samples, e.g. injecting samples
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N15/00—Investigating characteristics of particles; Investigating permeability, pore-volume or surface-area of porous materials
- G01N15/10—Investigating individual particles
- G01N15/14—Optical investigation techniques, e.g. flow cytometry
- G01N15/149—Optical investigation techniques, e.g. flow cytometry specially adapted for sorting particles, e.g. by their size or optical properties
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
- G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
- G01N2333/4701—Details
- G01N2333/4718—Lipocortins
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T436/00—Chemistry: analytical and immunological testing
- Y10T436/11—Automated chemical analysis
- Y10T436/117497—Automated chemical analysis with a continuously flowing sample or carrier stream
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T436/00—Chemistry: analytical and immunological testing
- Y10T436/25—Chemistry: analytical and immunological testing including sample preparation
- Y10T436/2575—Volumetric liquid transfer
Definitions
- a va ⁇ ety of cell-based assays are of considerable commercial relevance in screening for modulators of cell-based activity.
- compounds which affect cell death can have profound biological activities and are desirably screened for in cell-based assays
- Cell death has become recognized as a physiological process important in normal development, hormonal regulation of va ⁇ ous tissues, and, e.g., in regulation of the receptor repertoires of both T and B lymphocytes.
- the finding that a pattern of morphological changes is common to many examples of programmed cell death (or PCD) led to the suggestion of a common mechanism, and the term "apoptosis" was defined to include both the morphological features and the mechanism common to such programmed cell death (Kerr et al., Br J.
- cell-based assays include va ⁇ ous methods for the preparative or analytic sorting of different types of cells.
- cell panning generally involves attaching an approp ⁇ ate antibody or other cell-specific reagent to a solid support and then exposing the solid support to a heterogeneous cell sample.
- Cells possessing, e.g., the corresponding membrane-bound antigen will bind to the support, leaving those lacking the approp ⁇ ate antigenic determinant to be washed away.
- Other well-known sorting methods include those using fluorescence-activated cell sorters ("FACSs"). FACSs for use in sorting cells and certain subcellular components such as molecules of DNA have been proposed in, e.g., Fu, AN. et al.
- one difficult in flowing assay systems is that, du ⁇ ng pressure-based flow of fluids in channels non-uniform flow -velocities are expenenced Faster fluid and mate ⁇ al flow is observed in the center of a moving fluid stream than on the edge of a moving fluid stream This non-uniform flow velocity reduces throughput for flowing assays, because assa ⁇ runs have to be spaced well apart in the fluid stream to prevent overlap of mate ⁇ als moving at different velocities
- the present invention relates to methods of focusing particles in microchannels, e g , to improve assay throughput, to sort particles, to count particles, or the like
- cells and other particles are focused in the center of, to one side of, or in other selected regions of microscale channels, thereby avoiding, e g , the above noted difficulties inherent in pressure-based flow of particles
- the device structures of the present invention are optionally integrated with other microfluidic systems
- Other reactions or manipulations involving cells, other particles, or fluids upstream of the detection zone are also optionally performed, e g , monito ⁇ ng drug interactions with cells or other particles
- the invention provides methods of providing substantially uniform flow velocity to particles flowing in a first microchannel
- the particles are optionally flowed in the microchannel, e g , using pressure - based flow, in which the particles flow with a substantially non-uniform flow velocity P ⁇ or to performing the flowing step, the particles are optionally sampled with at least one capillary element, e g , by dipping the capillary element into a well containing the particles on a microwell plate and drawing the particles into, e g , reservoirs, microchannels, or other chambers of the device
- the particles e g , a cell, a set of cells, a microbead, a set of microbeads, a functionalized microbead, a set of functionalized microbeads, a molecule, a set of molecules, etc
- the particles are ho ⁇ zontally focused in the microchannel, e g , by introducing a low density fluid and a high density fluid into the microchannel, causing the particles to be focused in an intermediate density fluid present between the high density fluid and the low density fluid
- the particles are also optionally focused in a top or a bottom portion of the microchannel by introducing a high or a low density fluid into the microchannel with the flowing particles
- the particles are vertically or ho ⁇ zontally focused in the microchannel, e g , by simultaneously introducing fluid flow from two opposing microchannels into the first microchannel du ⁇ ng flow of the particles in the first channel
- Vertical focusing is also optional achieved to one side of a microchannel by simultaneously introducing fluid flow from, e g , a second microchannel into the first microchannel du ⁇ ng flow of the particles in the first microchannel
- the invention also provides particle washing or exchange techniques For example, focused cells or other particles are optionally washed free of diffusible mate ⁇ al by introducing a diluent into the first microchannel from at least a second channel and removing the resulting diluted diffused product comp ⁇ sing diluent mixed with the diffusible mate ⁇ al through at least a third microchannel
- the methods of the invention include simultaneously introducing the diluent into the first microchannel from the second microchannel and a fourth microchannel, where the second and fourth microchannel intersect the first microchannel at a common intersection region
- the methods include sequentially introducing the diluent into the first microchannel from the second microchannel and a fourth microchannel, wherein the second and fourth microchannels intersect the first microchannel at an offset intersection region
- the diffused product is typically removed through the third microchannel and a fifth microchannel, which third and fifth microchannels intersect the first microchannel at a common intersection region
- the diluent is introduced through sixth and seventh microchannels which intersect the first microchannel at a common intersection
- the resulting further diluted diffused product is removed through eighth and ninth microchannels, which intersect the first microchannel at a common intersection Diluent is optionally introduced into the first microchannel by pressure or electrokinetic flow
- the particles are cells and the method includes performing a TUNEL assay or an Annexin-V on the cells in the channel to measure apoptosis
- An integrated system for providing substantially uniform flow velocity to flowing members of at least one particle population in a microfluidic device optionally includes a body structure that includes at least a first microchannel disposed therein
- a first fluid direction component e g , a fluid pressure force modulator
- the first fluid direction component generally induces non-uniform flow
- a source of at least one fluidic mate ⁇ al is optionally fluidly coupled to the first microchannel
- the system also optionally includes at least a second microchannel that intersects the first microchannel for introducing at least one fluid into the first microchannel to ho ⁇ zontally or vertically focus the members of the at least one particle population in the first microchannel
- the at least one fluid is optionally introduced using a second fluid direction component that includes one or more of a fluid pressure force modulator, an electrokinetic force modulator, a capillary force modulator, a fluid wicking element, or the like
- At least one fluid is optionally introduced using a second fluid direction component that includes one or more of a fluid pressure force modulator
- this integrated system additionally includes at least a third microchannel which intersects the first microchannel in an intersection region common to the second microchannel
- the flow control regulator of this system optionally further regulates flow of the at least one fluid in the second and the third microchannels
- the computer typically also includes an instruction set for simultaneously flowing fluids from the second and third microchannels into the first microchannel
- at least fourth and fifth channels which intersect the first microchannel at a common intersection downstream of the second and third microchannels are provided
- the computer further includes an instruction set for simultaneously flowing mate ⁇ al from the first microchannel into the fourth and fifth microchannels
- Sixth and seventh microchannels which intersect the first microchannel at a common intersection downstream of the fourth and fifth microchannels
- the computer further comp ⁇ sing an instruction set for simultaneously flowing mate ⁇ al from the sixth and seventh microchannels into the first microchannel are optionally provided
- eighth and ninth microchannels which intersect the first microchannel at a common intersection downstream of the sixth and seventh microchannels, the computer further including an instruction set for
- the integrated system optionally includes sources for any reagent or particle used in the methods noted above, such as one or more sources of terminal deoxynucleotide transferase, one or more sources of one or more fluorescein labeled nucleotides or other labeled polynucleotides, one or more sources of Annexm V, one or more sources of an AnnexinV-biotin conjugate, one or more sources of a DNA dye, one or more sources of Campthotecin, one or more sources of Calcein-AM, one or more sources of a control cell, one or more sources of a test cell, etc
- Signal detector(s) mounted proximal to the first microchannel for detecting a detectable signal produced by one or more of the members of the at least one particle population in the microchannel are typically provided in the integrated systems of the invention
- the detector also optionally includes, e g , a fluorescent excitation source and a fluorescent emission detection element
- the computer is operably linked to the signal detector and has an instruction set
- the integrated system typically additionally includes a third and a fourth microchannel which intersect the first microchannel downstream from the intersection of the second microchannel with the first microchannel.
- the fourth microchannel also generally intersects the first microchannel downstream from the intersection of the third microchannel with the first microchannel.
- the flow control regulator of this system optionally further regulates flow of the at least one fluid in the third or the fourth microchannels.
- the signal detector typically detects a detectable signal produced by a selected member of the particle population between the intersections of the second and the third microchannels with the first microchannel.
- the computer is optionally operably linked to the first or other fluid direction component(s), the flow control regulator, and the signal detector.
- the instruction set typically directs simultaneous introduction of the at least one fluid from the third microchannel into the first microchannel to ho ⁇ zontally or vertically focus the selected member of the particle population such that the selected member is directed into the fourth microchannel in response to the detectable signal produced by the selected member.
- the instruction set further directs simultaneous introduction of the at least one fluid from the third microchannel by activating a heating element (e.g., a Joule heating electrode, a conductively coated microchannel portion, etc.) disposed within the third microchannel or a well that fluidly communicates with the third microchannel.
- a heating element e.g., a Joule heating electrode, a conductively coated microchannel portion, etc.
- the first microchannel optionally includes a separation element disposed therein.
- the separation element optionally includes, e.g , two sides and at least a portion of the separation element is typically disposed upstream of the fourth microchannel.
- a selected member of the particle population is generally directed to one of the two sides of the separation element and into the fourth microchannel that intersects the first microchannel in response to the detectable signal produced by the selected member
- the integrated system for use in particle sorting also optionally includes a fifth microchannel which intersects the first microchannel in an intersection region common to the second microchannel
- the flow control regulator also typically regulates flow of the at least one fluid in the second and the fifth microchannels
- the computer optionally includes an instruction set for simultaneously flowing fluids from the second and the fifth microchannels into the first microchannel
- the system also optionally includes a sixth microchannel which intersects the first microchannel in an intersection region common to the third microchannel.
- the flow control regulator optionally additionally regulates flow of the at least one fluid in the third and the sixth microchannels.
- the computer also typically includes an instruction set for flowing fluids from the third and the sixth microchannels into the first microchannel.
- the instruction set directs individual or simultaneous fluid flow from the third and sixth microchannels by individually or simultaneously activating at least one heating element (e.g., a Joule heating electrode, a conductively coated microchannel portion, or the like) disposed within each of the third and sixth microchannels or within at least one well that fluidly communicates with each of the third and sixth microchannels.
- at least one heating element e.g., a Joule heating electrode, a conductively coated microchannel portion, or the like
- kits for practicing the methods of the invention are also contemplated BRIEF DESCRIPTION OF THE FIGURES
- Figure 1A is a schematic showing focusing of cells in a microscale system by simultaneous flow from side channels into a main channel through which the cells are being flowed
- Figure IB is a photomicrograph of focused labeled cells flowing in a microchannel
- Figure 2A is a schematic of a microfluidic system with a pressure- source (in this case a vacuum source) for achieving fluid movement
- Figure 2B shows a cross-sectional view down a channel having high, medium and low fluid density.
- Figure 3 is a schematic drawing of a microfluidic system adapted to washing reagents from microparticles.
- Figure 4 is a data graph illustrating a control analysis, e.g., U937 cells not treated to induce apoptosis
- the bottom line corresponds to the SYTO®-62, which indicates the mere presence of cells, whereas the top line corresponds to the fluorescein end labeled nucleic acids.
- Figure 5 is a data graph illustrating U937 cells treated with Campthotecin to induce apoptosis. As can be seen, corresponding peaks are seen on both the lower and upper lines, indicating the presence of apoptotic cells.
- Figure 6 is a data graph illustrating an analysis of U937 cells that were not treated to induce apoptosis.
- the bottom line indicates live cell count (Calcem), while the top line indicates the presence of apoptotic cells (Annexm-V- Cy5).
- Figure 7 is a data graph showing an analysis of U937 cells treated with Campthotecin to induce apoptosis. The top trace includes a much greater number of peaks representing apoptotic cells, and particularly as a percentage of total cells in the analysis, e.g., as compared to the lower line.
- Figure 8 is a data graph showing results from a TUNEL assay with HL-60 cells treated with Campthotecin for 6 hours to induce apoptosis.
- the bottom line traces the total cell count
- the top line traces apoptotic cells labeled at DNA damage points. In this case, almost all cells had sustained apoptotic DNA damage
- Figure 9 is a data graph showing results from a TUNEL assay.
- HL-60 cells (not treated for apoptosis) were used as control cells
- the bottom trace is for SYTO®-62 indicating total cell count
- the top trace is for fluorescein labeled nucleotide which signifies the presence of apoptosis related DNA damage
- Figure 10 is a data graph showing results from TUNEL assays from Figures 8 and 9 analyzed using approp ⁇ ate software Data is presented as scatter plot format in Figure 10.
- Figure 11 is a data graph showing results from TUNEL assays from data represented in bar graph format. Additional data for different time points and two other cell lines is included.
- Figure 12 is a data graph showing an Annexin-V assay.
- HL60 cells were treated with Campothotecin for four hours to induce apoptosis
- the bottom trace indicates live cell count (Calcein).
- the top trace indicates Annex ⁇ n-V-Cy5 labeling. Cells labeled only for Calcein are live cells and not apoptotic. In this case, almost all cells are apoptotic
- Figure 13 is a data graph showing an Annexin-V assay.
- HL-60 cells (not treated for apoptosis) are control cells.
- the bottom trace indicates live cell count
- the top trace indicates Annexm-V-Cy5 labeling.
- Cells labeled with both dyes are apoptotic.
- Cells labeled only for Annex ⁇ n-Cy5 are dead cells. In this case, only a few cells were apoptotic.
- Figure 14 is a data graph showing data analysis of Figures 12 and 13. Data is presented in scatter plot format in Figure 14.
- Figure 15 is a data graph showing data represented in bar graph format.
- Figure 16 shows a "T-junction" microchannel configuration for hydrodynamically focusing cells for use in, e.g., flow cytometry.
- Figure 17 depicts a chip design used to conduct fluorescence population focusing expe ⁇ ments.
- Figure 18 is a histogram showing the dist ⁇ bution of results obtained in a fluorescence intensity population expe ⁇ ment conducted utilizing hydrodynamic focusing.
- Figures 19 and 20 are histograms showing the dist ⁇ bution of results obtained in fluorescence intensity population expe ⁇ ments conducted in the absence of hydrodynamic focusing.
- Figure 21 is a microchannel network that is optionally utilized to hydrodynamically focus particles.
- Figure 22 is a schematic illustration of a particle sorting configuration utilizing sets of opposing microchannels to focus and/or otherwise direct the flow of the members of, e.g., a cell population to achieve cell sorting.
- Figure 23 is a schematic representation of a microchannel configuration that includes one separation element embodiment.
- Figure 24 is a schematic depiction of a microchannel configuration that includes Joule heating electrodes for use in particle sorting.
- Figures 25A, B, and C are histograms showing the distribution of results obtained in resolution experiments using various microbead concentrations.
- Figure 26 is a histogram showing the distribution of results obtained in a resolution experiment using viable cells stained with an intercalating dye.
- the invention relates to particle focusing to improve assay throughput by regularizing flow velocity.
- the term "particle” refers to a discretely describable material element, such as a cell, microbead (e.g., functionalized or non-functionalized), molecule (e.g., a nucleic acid, a polypeptide, etc.), or the like.
- a particle typically includes, e.g., a soluble or non-soluble component of a fluid mixture, such as a solubilized or suspended molecule, liposome, cell, organelle, bead, or the like.
- the particle is a detectable unit; for example, in the case of molecular particles, the particle is detectable, e.g., via a label.
- microbeads and cells are detected, e.g., optically or through an associated label (this detection is also optionally, e.g., optical or via fluorescence).
- This detection is also optionally, e.g., optical or via fluorescence.
- the following provides details regarding various aspects of the methods of focusing particles, e.g., vertically and/or horizontally within the microscale systems of the invention. It also provides details pertaining to methods of washing cells and to particular assays, such as cell viability screening, which are optionally performed using the methods and devices of the present invention. Devices and integrated systems are also discussed extensively. LAMINAR FLOW VERTICAL FOCUSING OF CELLS AND OTHER PARTICLES IN MICROSCALE SYSTEMS
- Microfluidic hydrodynamic focusing is a highly effective technique when used, e g., in flow cytometry applications, such as the assessment of live/dead cell ratios, the analysis of transfection efficiencies, the sizing of va ⁇ ous molecular components (e g., polynucleotides, polypeptides, etc ), the study of apoptosis, or the like.
- flow cytometry applications such as the assessment of live/dead cell ratios, the analysis of transfection efficiencies, the sizing of va ⁇ ous molecular components (e g., polynucleotides, polypeptides, etc ), the study of apoptosis, or the like.
- Fluid flow streams are optionally "pinched” or “focused” into a narrow region of a microchannel to facilitate single particle or narrow streamline detection using a va ⁇ ety of optical detection schemes (discussed further, below)
- particle focusing is achieved electrodynamically (see also, Ramsey et al., "Apparatus and Method for Performing Electrodynamic Focusing on a Microchip," U.S. Pat. No 5,858,187, issued January 12, 1999)
- pressure, Joule heating, and or other fluid movement methods are used to focus cells or other particles.
- a "vertically" focused particle stream refers to a particle stream that is substantially focused, pinched, narrowed, or otherwise confined along or proximal to a plane that extends, in one dimension, from the highest to the lowest internal surface of a microchannel (e.g., along the length of a cross-sectional line or axis of the microchannel), and along a selected length of the microchannel, in another dimension, when the microfluidic device is o ⁇ ented for typical operational usage.
- a vertically focused particle stream corresponds to a plane that is o ⁇ ented approximately 90° from a plane in which a ho ⁇ zontally focused particle stream (discussed below) would be o ⁇ ented.
- Vertical focusing is optionally achieved by flowing fluids into a microchannel (e.g., from one or more sides of the microchannel) in which a particle stream is flowing to focus the particles along or proximal to the vertical plane having a dimension that corresponds to a selected vertical line or axis of the microchannel.
- the level of focusing along or proximal to the vertical plane is optionally va ⁇ ed.
- a particle stream is also optionally vertically focused away from the vertical cross-sectional axis, e.g., to one side of a microchannel.
- An additional option includes simultaneously ho ⁇ zontally and vertically focusing a particle stream to position the stream within a desired region of a microchannel.
- the measurement of fluorescent signals associated with single cells (or other particles) in microfluidic channels is difficult if the cells or particles are randomly disbursed in the channels
- the channels are usually about 100 ⁇ m or larger in width to prevent clogging by particle aggregates; however, particles such as cells are typically on the order of 10 ⁇ m in diameter
- An interrogating light beam is focused on a spot usually much less than the 100 ⁇ m width of the channel
- it is useful, e g to center particles in the channel, to position particles to one side of a channel, or to otherwise focus flowing particles in a portion of a channel p ⁇ or to detection to obtain accurate fluorescent readings on all the particles passing through the channel
- Figure 1 A shows an example cell (or other particle) analysis chip design for on-chip focusing
- the microchannel network geometry includes a cross formed by four microchannels that intersect in a common intersection region
- Figure IB shows a photomicrograph of this microchannel configuration with focused labeled cells flowing in a main or analysis microchannel
- Cells or other particles are optionally flowed in the main microchannel and/or focused using va ⁇ ous methods, which include the use of electrokinetic forces, pressure gradients, surface tension gradients, gravitational forces, or the like
- va ⁇ ous methods include the use of electrokinetic forces, pressure gradients, surface tension gradients, gravitational forces, or the like
- a preferred method of flowing particles in the mam microchannel utilizes pressure-based flow.
- cells 100 are typically flowed from one microchannel into the cross-junction and focused by introducing hydrodynamic flows 102 from the two orthogonal microchannels
- Non- orthogonal (e.g., opposing or non-opposmg) microchannels are also optionally used
- particles are optionally focused with a single focusing microchannel, or alternately, by using a se ⁇ es of offset focusing microchannels to achieve focusing by se ⁇ al introduction of fluids from the offset channels
- cells 100 are optionally constrained to the center of a detection microchannel downstream from the two orthogonal microchannels by hydrodynamic flows 102 introduced from both sides as cells 100 pass through detector 104 Using these methods, an expe ⁇ ment is optionally conducted which uses, e.g , a small optical detection system on the order of the size of the particular cell or other particle being analyzed to de ⁇ ve accurate and precise measurements
- Figure 21 depicts a microchannel network that is optionally used to hydrodynamically focus particles, e g., cells, microbeads, molecules, or the like in parallel through common detection zone 2100
- five cell suspensions are typically loaded into wells 2102 and flowed towards common detection zone 2100.
- Cell buffer solutions are also typically loaded into particular wells (e.g., well 2104) in the device and flowed towards common detection zone 2100
- each microchannel in which cells are flowed intersects with two buffer flowing microchannels in a cross-configuration to focus the cells as they pass through common detection zone 2100
- a "T-junction" microchannel geometry is optionally used to focus cells or other particles 1600 to one side of detection microchannel 1604.
- a "T-junction” typically includes an orthogonal intersection of two microchannels
- microchannel geomet ⁇ es that include non-orthogonal intersections are also optionally used (e.g., a "Y-junction” or the like).
- cells or other particles 1600 are typically flowed from one well 1602 and pinched to one side of detection microchannel 1604 by only one other introduced fluid stream 1606 and the wall of detection microchannel 1604 opposing the "T-junction" as cells or other particles 1600 pass through detector 1608.
- This embodiment generally achieves the same effect as the cross-microchannel formats, but with the added advantage of using less space on the microfluidic device due to the use of one focusing channel, rather than two which, in turn, provides for greater parallelism or complexity in chip design, and for more control of the hydrodynamic focusing mechanism.
- the focusing of flow to one side of a microchannel also provides a solution to va ⁇ ous problems associated with controlling fluid flow under lower pressures (e.g., difficulties regulating fluid direction pumps, etc.).
- the resistance produced by pinching fluid mate ⁇ als against microchannel walls functions to reduce the velocity of the pinched fluid stream
- pinched fluids are optionally flowed under higher pressures, e.g., for greater control, while achieving comparable low pressure flow velocities Resistance is also altered, e.g., by varying the viscosity of pinched fluid mate ⁇ als. which provides an added level of control over flow rates and the extent of fluid pinching
- the throughput is increased if all of the cells or microparticles move at a common velocity
- the parabolic nature of pressure-based flow causes cells at the center of a flow stream to move faster than those near the walls of a channel This phenomenon causes dispersion in the system since cells can move from one sample into another
- high and low density fluid streams are incorporated into fluid flow of the cells or particles
- the high density fluid keeps the cells or other microparticles off of the bottom of the channel, while the low density fluid keeps cells or microparticles off of the top of the microchannel, thereby focusing the cells in the center of the fluid stream Even after diffusion b ⁇ ngs the high, low, and middle density fluids into equi b ⁇ um, the cells generally remain focused in the center of a microchannel
- the point in the microchannel in which the high and low density fluids are flowed into the mam channel is deeper than other channel regions to improve dist ⁇ bution of the different density fluids
- a "ho ⁇ zontally" focused particle stream refers to a particle stream that is substantially focused, pinched, narrowed, or otherwise confined along or proximal to a plane that extends, in one dimension, from one substantially vertical internal microchannel surface to another (e g., substantially parallel to the dimension of the lowest internal microchannel surface that extends from one vertical internal surface to another), and along a selected length of the microchannel, m another dimension, when the microfluidic device is o ⁇ ented for typical operational usage.
- a ho ⁇ zontally focused particle stream corresponds to a plane that is o ⁇ ented approximately 90° from a plane in which a vertically focused particle stream (discussed above) would be onented.
- ho ⁇ zontal particle focusing typically involves using focusing fluids having densities that differ relative to the density of a particle stream
- higher density fluids are optionally used to substantially prevent the particle stream from contacting the lowest internal surface of the microchannel over a particular length.
- a less dense focusing fluid is optionally used to substantially prevent the particle stream from contacting the highest internal surface of the microchannel over a selected length
- both lower and higher density focusing fluids are optionally flowed simultaneously to substantially prevent the particle stream from contacting either the highest or lowest internal microchannel surfaces.
- FIG. 2A is a schematic representation of a microfluidic system that uses vacuum source 210 to achieve fluid movement
- test compounds are typically flowed through capillary channel 200 (capillary channels or elements are discussed in greater detail, below) into a detection microchannel of the device.
- High density buffer and low density buffer are optionally flowed into the detection microchannel through high density buffer microchannel 202 and low density buffer microchannel 204, respectively, both of which intersect the detection microchannel upstream from detector 208.
- Cell microchannel 206 typically intersects the detection microchannel downstream from the intersections of high density buffer microchannel 202 and low density buffer microchannel 204, but upstream from detector 208.
- Cells in medium density buffer are typically flowed into the detection channel from cell microchannel 206, becoming focused between the high and low density buffers, and exposed to the test compounds p ⁇ or to flowing through detector 208.
- Figure 2B shows a cross-sectional view down the detection microchannel which includes low density buffer 214, cells 212, and high density buffer 216.
- Fluid density-based focusing also optionally entails focusing cells or other particles either at the top or the bottom of a microchannel.
- a high density fluid is optionally flowed into a microchannel to keep cells or other particles off of the bottom of the microchannel, i.e., focused at the top of the microchannel.
- a low density fluid is flowed into a microchannel to keep cells or other particles off of the top of the microchannel, i.e , focused on the bottom of the microchannel
- ho ⁇ zontal and vertical focusing are optionally both performed to center cells vertically and ho ⁇ zontally in the center of microscale channels
- the extent of hydrodynamic focusing, using either or both methods is typically controlled by a va ⁇ ety of va ⁇ ables including viscosity in pressure d ⁇ ven flows, electrokinetic mobility in electrokinetic flow, fluid density in gravity d ⁇ ven flow, or the like
- the enhanced control of focusing provided by the present invention, allows for a large gamut of flow-based applications, including any particle and/or bulk fluid application that involves small, uniform detection regions.
- the separation of fluorochrome-labeled cells with fluorescence- activated cell sorters is well-known in the art, as mentioned above.
- the technique generally involves incubating a mixed population cells with a fluorescently- labeled antibody against a specific antigenic determinant displayed on the surfaces of target cells. The suspension of cells is then typically expelled, one cell at a time, from a sample chamber of the device through a small vibrating nozzle that generates microdroplets. Each rmcrodroplet contains a single cell that the FACS assays for the presence or absence of the fluorochrome label using a laser source and a detector. Droplets that fluoresce are elect ⁇ cally charged in proportion to their fluorescence and in turn separated as they pass between charged plates.
- the present invention provides microfluidic devices and methods for sorting particles (e.g., fluorescently-labeled particles) that use hydrodynamic flow to focus and/or sort the particles
- the methods for sorting members of a particle population typically include flowing the members of a particle population in a first microchannel
- the members of the particle population are focused ho ⁇ zontally and/or vertically in the first microchannel such that selected individual members are directed into at least a second microchannel that intersects with the first microchannel
- a portion of the first microchannel optionally includes at least one separation element disposed therein
- the separation element generally includes at least two sides in which at least a portion of the separation element is disposed upstream of the second microchannel
- the members of the particle population are optionally focused ho ⁇ zontally and/or vertically in the first microchannel such that selected individual members are directed to at least one of the at least two sides of the separation element and into, e.g , at least a second microchannel that intersects the first microchannel
- this separation element is omitted
- the focusing steps of the particle sorting methods optionally include ho ⁇ zontally and or vertically focusing the members of the particle population in the first microchannel by introducing at least one fluid flow (e g., a buffer, a high density fluid, a low density fluid, or the like) from at least a third microchannel that intersects with the first microchannel upstream from, e.g., the second microchannel.
- at least one fluid flow e g., a buffer, a high density fluid, a low density fluid, or the like
- This is optionally performed by any method for flowing fluid in a microfluidic device, including electrokinetic flow, pressure-based flow, and the like.
- methods employing electrostatic forces to transport and focus samples generally involve inducing sample flow in a transport channel by applying a first elect ⁇ cal potential to the channel Thereafter, a second elect ⁇ cal potential is typically applied to focusing channels that intersect with the transport channel in a cross-configuration to vertically focus the transported sample in the center of the transport channel
- This electrokinetic-based system is also optionally utilized to direct or "nudge" flowing samples to effect a sorting function, e g., by applying an elect ⁇ cal potential to at least one of the intersecting focusing channels to direct sample flow to ards or away from that focusing channel and into, e g., an additional intersecting channel or into a channel region That is, electrokinetic force can be applied to "nudge" mate ⁇ als across the width of a first channel at an intersection of the first channel and a second channel, resulting in downstream focusing of mate ⁇ als in the channel
- This application of electrokinetic force is optionally electrokinetic, electroosmotic, or both See also, e g , Ramsey
- the fluid flow is induced by heating (e.g., Joule heating, etc ) a fluid in the third microchannel
- the focusing steps include ho ⁇ zontally and/or vertically focusing the members of the particle population in the first microchannel by introducing at least one fluid flow from at least one of at least a third and at least a fourth microchannel that oppose one another and that intersect with the first microchannel upstream from the second microchannel.
- the fluid flow is optionally introduced by heating (e.g , Joule heating or the like) a fluid in at least one of the third or fourth microchannels
- FIG 22 schematically illustrates one particle sorting configuration utilizing these methods.
- cells 2200 are generally flowed in a main microchannel that includes at least two sets of opposing microchannels for focusing and/or otherwise directing the flow of cells 2200 using hydrodynamic flow 2202 (e.g , cell buffer flow).
- hydrodynamic flow 2202 e.g , cell buffer flow
- One set of opposing microchannels is typically located, e.g , upstream from detector 2204 for simultaneously introducing hydrodynamic flow 2202 from both microchannels to focus cells 2200, as desc ⁇ bed above
- a second set of opposing microchannels is typically located downstream from detector 2204 for introducing at least one hydrodynamic flow 2202 so as to direct selected cells 2208 (e.g , fluorescently-labeled cells) and non-selected cells 2206 into, in this case, one of two microchannels, each terminating in particular collection wells 2210
- Figure 23 schematically depicts a microchannel configuration that includes one embodiment of separation element 2310
- cells 2300 are typically flowed in a microchannel that intersects with another microchannel located upstream from detector 2304
- the upstream intersecting microchannel is optionally used to focus cells 2300 to one side of the microchannel as cells 2300 pass through detector 2304 using hydrodynamic flow 2302
- This illustration also includes a set of opposing microchannels located downstream from the detector for introducing at least one hydrodynamic flow 2302 to direct selected cells 2308 (e.g , fluorescently-labeled cells) and non-selected cells 2306 to either side of separation element 2310 and into, in this case, one of two microchannels, each terminating in particular collection wells 2312.
- selected cells 2308 e.g , fluorescently-labeled cells
- Separation element 2310 is optionally omitted, with cells 2300 or other particles being directed into destination regions as desired
- the inverse relationship between temperature and viscosity for va ⁇ ous buffers, gels, and other mate ⁇ als is also optionally exploited in the present invention to effect particle sorting
- a desired particle e.g., a buffer or gel disposed in a downstream side-channel is typically heated to decrease fluid viscosity (i.e., to induce fluid flow) to thus direct particles within the microfluidic device.
- a desired particle e.g., a buffer or gel disposed in a downstream side-channel is typically heated to decrease fluid viscosity (i.e., to induce fluid flow) to thus direct particles within the microfluidic device.
- Joule heating is a preferred method.
- Joule heating is typically produced by flowing current through an electrode or other conductive component positioned within a well, microscale channel, or other cavity within the device. The resulting flow of current into fluid within the well, channel, or cavity results in resistive heating of the fluid. By substantially increasing the current across the channel, rapid temperature changes are induced that are optionally monitored by conductivity. Because nano ter volumes of fluid have tiny thermal mass, transitions between temperatures are typically extremel) short.
- the present invention optionally uses power sources that pass elect ⁇ cal current through, e.g., a focusing channel region for heating purposes
- fluid passes through a channel of a desired cross-section (e g , diameter) to enhance thermal transfer of energy from the current to the fluid
- a desired cross-section e.g , diameter
- the channels are optionally formed on almost any type of substrate mate ⁇ al such as, amorphous mate ⁇ als (e g , glass, plastic, silicon), composites, multi-layered mate ⁇ als, combinations thereof, or the like
- a portion of the power goes into kinetic energy for moving the fluid through the channel.
- a selected portion of the power to controllably heat fluid in a channel or selected channel regions, e.g., to further induce fluid movement by reducing fluid viscosity.
- a channel region suitable for heating is optionally narrower or smaller in cross-section than other channel regions in the channel structure, as a smaller cross-section provides higher resistance in the fluid, which increases the temperature of the fluid as elect ⁇ c current passes through.
- the elect ⁇ c current is increased across the length of the channel by increased voltage, which also increases the amount of power dissipated into the fluid to correspondingly increase fluid temperature.
- a power supply applies voltage and/or current in va ⁇ ous ways.
- a power supply optionally applies direct current (i.e., DC) or alternating current (AC), which passes through the channel and into a channel region which is, e.g., smaller m cross- section to heat fluid in the region.
- DC direct current
- AC alternating current
- a power supply applies a pulse or impulse of current and or voltage, which passes through the channel and into a channel region to heat fluid in the region Pulse width, shape, and/or intensity are optionally adjusted, e.g., to heat the fluid substantially while moving the fluid.
- the power supply optionally applies any combination of DC, AC, and pulse, depending upon the application
- direct application of elect ⁇ c current to fluids in the microchannels of the invention results in extremely rapid and easily controlled changes in temperature.
- a controller or computer such as a personal computer is generally used to monitor the temperature of the fluid in the region of the channel where the fluid is heated.
- the controller or computer typically receives current and voltage information from, e.g., the power supply and identifies or detects fluid temperature in the channel region.
- the controller or computer also typically receives current information from an operably connected detector, e.g., when a selected particle is detected, which triggers the flow of current through, e.g., one or more Joule heating electrodes.
- the controller or computer adjusts voltage and/or current to meet the desired fluid temperature.
- the region which is heated optionally includes a "coil" which is typically in a planar arrangement. Transfer of heat from the coil to a channel through a substrate material is used to heat the focusing fluids, gels or other materials disposed in the channel. Alternatively, the coil itself is optionally the focusing channel. A voltage is applied between regions of the coil to direct current through the fluid for heating purposes. In particular, a power supply provides a voltage differential between regions of the coil. Current flows between the regions and traverses a plurality of coils or coil loops, which are defined by a substrate. The shape and size of the coils typically influences an ability of current to heat the fluid in the coil. As current traverses through the fluid, energy is transferred to the fluid for heating purposes. Cooling coils are also optionally included.
- FIG. 24 One embodiment of Joule heating-based particle sorting is schematically illustrated in Figure 24.
- particles are typically flowed from particle well 2400 into main microchannel 2402.
- focusing microchannel 2404 intersects with main microchannel 2402 in a "T- junction" upstream from detector 2408.
- focusing flow stream 2406 is optionally used to focus or pinch the particles against the wall of main microchannel 2402 opposing the "T-junction" as the particles flow through detector 2408.
- an electrical signal from detector 2408 typically triggers the flow of current to Joule heating electrodes 2416, which are disposed within wells of branched particle sorting microchannel 2418.
- branched particle sorting microchannel 2418 includes more than two branches or is a single, unbranched microchannel. Additionally, greater or less than two Joule heating electrodes 2416 are optionally included.
- conductive coatings are also optionally included in lieu of or in addition to the heating electrodes for effecting the flow of a focusing fluid.
- the heat produced by current flowing from Joule heating electrodes 2416 raises the temperature of, e.g., a buffer or gel disposed within branched particle sorting microchannel 2418, thus reducing hydrodynamic resistance in the buffer or gel.
- the reduced viscosity in conjunction with vacuum source(s) that are typically operably connected to the device at non-selected particle collection well 2420 and/or selected particle collection well 2422, induce or increase flow of the buffer or gel from branched particle sorting microchannel 2418, which intersects main microchannel 2402 downstream from detector 2408.
- the induced flow of buffer or gel into main microchannel 2402 thus deflects or redirects the flow of selected particle 2410 into selected particle collection well 2422.
- non- selected particle 2412 does not trigger Joule heating/redirecting flow and as such, flows unimpeded into non-selected particle collection well 2420.
- one or both microchannels of the second set of opposing microchannels located downstream from detector 2204 optionally include one or more Joule heating electrodes (e.g., 1, 2, 3, 4, 5, or more electrodes) and/or conductive coating portions.
- One or both of the opposing microchannels also optionally includes a branched channel structure similar to the branched structure depicted in Figure 24, above (i.e., branched particle sorting microchannel 2418).
- one or both of the opposing microchannels includes greater than two branches, each branch of which optionally includes one or more Joule heating electrode(s).
- separation elements such as those discussed above are optionally included.
- Preferred buffers, gels, and other materials used the in these heating embodiments have relatively sharp temperature/viscosity transitions in a narrow temperature range and are generally known in the art. Joule heating is described further in, e.g., in 08/977,528, entitled “Electrical Cu ⁇ ent for Controlling Fluid Temperatures in Microchannels,” filed November 25, 1997 by Calvin Chow, Anne R. Kopf-Sill and J. Wallace Parce; and in PCT/US98/06723, entitled “Closed-Loop Biochemical Analyzers,” filed April 3, 1998, by Knapp. There are various other techniques that are also optionally used to heat buffers, gels, and other materials to effect particle focusing.
- resistive heating typically results from current applied to conductively coated well or microchannel portions, from one or more electrodes directly (e.g., a thermocouple, etc.), or the like.
- Other heating methods optionally include directing, e.g., light from a laser source through one or more fiber optic cables to, e.g., wells that fluidly communicate with focusing channels. Heat from other external sources is also optionally utilized in the methods described herein.
- the invention provides in-system cell washing capability. This concept is also optionally extended to washing any other particulate sample.
- diffusible substances such as antibodies, proteins, salts, drugs, etc. are removed by washing the materials away from the particles in a microscale system.
- lateral channels are placed downstream of the point at which diffusible substances are present in a central main channel.
- wash buffer is typically injected simultaneously from both sides of the main channel from lateral wash channels 306.
- wash buffer is optionally sequentially introduced into the main channel from lateral wash channels that intersect the main channel in an offset intersection region (i.e., the lateral wash channels are at least somewhat staggered, instead of intersecting directly across from one another). This buffer is then generally removed by flowing the diffusible material into another set of lateral wash channels 308.
- wash in-wash out steps diffusible materials are removed from the main channel. Thereafter, labeled cells are optionally detected in detection zone 314 and subsequently flowed into waste well 316.
- the cells or other particles remain centered in the main channel and do not flow into the lateral wash channels, preventing clogging of the wash channels.
- Flow in the main channel, and in the wash channels is optionally performed by electrokinetic or pressure-based flow of materials.
- the methods and systems of the present invention are particularly applicable in performing cell viability assays as well as for screening test compounds for their effects on cell viability.
- Such assays are generally utilized in performing toxicity studies, antibiotic screening methods, or the like, and are particularly suitable for the methods and systems of the present invention.
- the cellular function specific indicator is an indicator of cell viability.
- the suspension of cells typically includes a label.
- the cells are optionally treated with a second function labeling group that indicates the viability of the cells in the suspension.
- the function label preferentially stains or labels either viable or non-viable cells.
- a variety of viability indicative dyes are generally commercially available.
- fluorogenic esterase substrates such as Calcein AM, BCECF AM and fluorescein diacetate
- these esterase substrates measure both esterase activity, which is required to activate the fluorescence of the dye, as well as cell-membrane integrity, which retains the fluorescent materials intracellular] y.
- viability indicators include polyfluorinated fluorescein derivatives (i.e., DFFDA, TFFDA, HFFDA and Br TFFDA), polar nucleic acid based dyes (i.e., SYTOX GreenTM), dimeric and monomeric cyanine dyes (i.e., TOTOTM and TO-PROTM series dyes from Molecular Probes), ethidium and propidium dyes (i.e., ethidium bromide, ethidium homodimer and propidium iodide).
- polyfluorinated fluorescein derivatives i.e., DFFDA, TFFDA, HFFDA and Br TFFDA
- polar nucleic acid based dyes i.e., SYTOX GreenTM
- dimeric and monomeric cyanine dyes i.e., TOTOTM and TO-PROTM series dyes from Molecular Probes
- ethidium and propidium dyes i.ethidium bromide, ethi
- the level of function label is indicative of the number of either viable or non-viable cells
- the level of reference label is indicative of the number of total cells, e.g., viable and non-viable. Comparison of the levels of the two labels then provides an indication of the relative viability of the cells in the suspension, regardless of the number of cells being detected, e.g., multiple cells, aggregates, or individual cells). In particular, where two cell populations show a similar level of reference label, but one population shows a lower level of viability indicator, it will be understood that the second population is less viable, e.g., has more nonviable cells. It will be appreciated that many dyes or labels described for use as reference labels are also often used as viability labels. Accordingly, it will generally be desirable to select a reference label that labels both viable and nonviable cellular material, and which is distinguishable from the function label. Examples of such reference labels include, e.g., lipophilic membrane labels, or the like.
- cell suspensions that are exposed to different test compounds or agents are flowed past the detection point and the relative viability of the cells is determined, as compared to a control. Increases or decreases in cellular viability indicate that the compound or agent improves or decreases cellular viability.
- Such assays are readily employed in identifying antimicrobial, antibiotic or other viability affecting agents.
- such assays are optionally employed in screening for effectors of pathways involved in apoptosis or programmed cell death, e.g., ras mediated pathways.
- the methods and devices of the present invention are optionally used to perform the cell viability assays described herein.
- cells exposed to selected test compounds are washed free of excess staining dyes or the like before being focused horizontally and/or vertically as they flow past a detection point to obtain accurate fluorescent readings (e.g., derived from function and/or reference labels).
- cells e.g., viable and non-viable cells
- hydrodynamic flow e.g.
- Adhesion of materials during pressure-based flow using prior art methods can be problematic, because the flow velocity at the channel wall is low. This low flow velocity increases the time that a material remains in position proximal to a given region of the microscale channel. This increased proximity to a single region leads to formation of strong interactions between the channel region and the material.
- one particular advantage of the present method is that focusing of materials in the center of microchannels inhibits adsorption of the materials to the walls of microscale channels and other microscale elements during flow of the materials.
- the methods and systems of the present invention are useful in assaying for virtually any cellular function, provided that either the function or a result of the function is independently detectable.
- a number of specific types of assays are generally used as screening models for the identification of potential drug candidates, or "lead compounds.”
- the assay types most frequently used in these screening operations generally include transport assays, binding assays, viability assays, and expression assays.
- the methods and systems of the present invention are used in assaying cellular transport functions, i.e., ion flux, and intracellular pH regulation.
- cellular transport channels have been generally shown to be responsive to important cellular events, e.g., receptor mediated cell activation, and the like.
- G-protein coupled receptors have been shown to directly or indirectly activate or inactivate ion channels in the plasma membrane or endosomal membranes of cells, thereby altering their ion permeability and thus effecting the excitability of the membrane and intracellular ion concentrations. See, Hille, Ionic
- the function specific label comprises an indicator of the level of a particular intracellular species.
- the intracellular species is an ionic species, such as Ca 2+ , Na + , K + , Cl " , or H * (e.g., for pH measurements).
- ionic species such as Ca 2+ , Na + , K + , Cl " , or H * (e.g., for pH measurements).
- H * e.g., for pH measurements.
- calcium indicators include analogs of BAPTA (l,2-bis(2-aminophenoxy)ethane-N,N,N',N'- tetraacetic acid), such as Fura-2, Fluo-2 and Indo-1, which produce shifts in the fluorescent excitation or emission maxima upon binding calcium, and Fluo-3 and Calcium Green-2, which produce increases in fluorescence intensity upon binding calcium.
- BAPTA l,2-bis(2-aminophenoxy)ethane-N,N,N',N'- tetraacetic acid
- Fura-2, Fluo-2 and Indo-1 which produce shifts in the fluorescent excitation or emission maxima upon binding calcium
- Fluo-3 and Calcium Green-2 which produce increases in fluorescence intensity upon binding calcium.
- Sodium and potassium sensitive dyes include SBFI and PBFI, respectively (also commercially available from Molecular Probes, Eugene OR).
- chloride sensitive indicators include 6- methoxy-N-(sulfopropyl)quinolinium (SPQ), N-(sulfopropyl)acridinium (SPA), N-(6- methoxyquinolyl)acetic acid, and N-(6-methoxyquinolyl)acetoethyl ester (Molecular
- the function specific indicator is an intracellular pH indicator compound.
- intracellular pH changes have been found to be associated with biologically and pharmaceutically important cellular events, including cell proliferation, apoptosis, fertilization, malignancy, ion transport, drug resistance, lysosomal storage disorders, and Alzheimer's disease.
- a variety of indicator compounds are commercially available to indicate the intracellular pH of cells, and are readily applicable to the present invention as indicators of cellular function.
- pH indicators examples include, e.g., SNARFL, SNARF, BCECF, and HPTS, available from Molecular Probes, Inc.
- a suspension of cells that is to be assayed is flowed along a channel.
- the cells include a reference label as described above, e.g., SYTO® dyes available from Molecular Probes.
- the cells are also treated with an intracellular indicator of the level of the species for which relative transport levels are to be determined, and which indicator is distinguishable from the reference label.
- the cells are optionally stained with, e.g., S YTO®-62 as a reference label.
- SYTO®-62 is a red nucleic acid dye that is generally excited by light at approximately 655 nm, and which emits light at approximately 675 nm.
- the cells are also optionally treated with an intracellular calcium indicator, e.g., Fluo-3, also available from Molecular Probes, which is excited at 488 nm and emits at approximately 530 nm.
- an intracellular calcium indicator e.g., Fluo-3, also available from Molecular Probes, which is excited at 488 nm and emits at approximately 530 nm.
- the two labels are easily distinguishable based upon their differing fluorescent emission maxima.
- the cells are illuminated with a broad spectrum of light, e.g., light that encompasses the excitation maxima of both the SYTO®-62 and Fluo-3 labels.
- Emitted fluorescence is then passed through optical filtering systems that separate and separately detect the SYTO®-62 fluorescence and the Fluo-3 fluorescence.
- the levels of fluorescence from each dye are then compared. For example, the comparison optionally includes plotting the level of reference label versus the level of function label. Over the course of the assay, a number of separate data points are gathered that represent different cells or groups of cells that are detected. These are plotted and the slope of the resulting line is calculated. Changes in this slope are indicative of changes in the level of the function that is being assayed.
- the methods and systems of the present invention are used in assaying cellular binding functions, such as ligand-receptor binding, nucleic acid hybridization, antigen/antibody binding, cell-cell interactions, and the like.
- cellular binding functions are often necessary precursors to a variety of cellular functions. Specifically, many biological responses are often triggered and or controlled by the binding of a receptor to its ligand.
- interaction of growth factors i.e., EGF, FGF, PDGF, etc.
- EGF e.g., EGF, FGF, PDGF, etc.
- their receptors stimulate a wide variety of biological responses including, e.g., cell proliferation and differentiation, activation of mediating enzymes, stimulation of messenger turnover, alterations in ion fluxes, activation of enzymes, changes in cell shape and the alteration in genetic expression levels.
- control of the interaction of the receptor and its ligand may offer control of the biological responses caused by that interaction.
- binding functions may be detected by detecting the downstream event for which binding is a precursor, e.g., enhanced or decreased transport function, expression of receptor linked reporter label, protein translocation, or by detecting actual binding of cells with a binding agent, e.g., a ligand, nucleic acid or the like, through the inclusion in the ligand of a binding indicator, e.g , fluorescent resonance energy transfer dyes (FRET), molecular beacons, etc.
- a binding agent e.g., a ligand, nucleic acid or the like
- a binding indicator e.g , fluorescent resonance energy transfer dyes (FRET), molecular beacons, etc.
- detection of binding may be accomplished by labeling the cells' surfaces with both elements of approp ⁇ ate FRET dyes, e.g., energy donor and energy acceptor Upon cell-cell binding, these elements are placed in sufficient proximity for energy transfer, allowing their detection.
- elements of approp ⁇ ate FRET dyes e.g., energy donor and energy acceptor
- fluorescence pola ⁇ zation detection methods are used to detect binding of relatively small molecules, e g , ligands, antibodies, etc., to relatively large structures, e.g., cells.
- Fluorescence pola ⁇ zation assays for use in microfluidic systems are generally desc ⁇ bed in Provisional U.S Application No. 60/088,650, filed June 8, 1998, incorporated herein by reference.
- a va ⁇ ety of other detection/labeling mechanisms are also available for detecting binding of one molecule, e.g., a ligand or antibody, to another molecule, e.g., a cell surface receptor.
- a number of labeling mate ⁇ als change their fluorescent properties upon binding to hydrophobic sites on proteins, e.g., cell surface proteins.
- Such labels include, e.g., 8-ammo-l -naphthalene sulfonate (ANS), 2-p- tolu ⁇ d ⁇ nylnaphthalene-6-sulfonate (TNS) and the like
- detectable enzyme labels are utilized that cause precipitation of fluorescent products on solid phases, i.e., cell surfaces are optionally used as function indicators of binding.
- alkaline phosphatase substrates that yield fluorescent precipitates are optionally employed in conjunction with alkaline phosphatase conjugates of cell binding components
- Such substrates are generally available from Molecular Probes, Inc., and are desc ⁇ bed in, e.g., U.S. 5,316,906 and U.S. 5,443,986. II.
- the present invention provides methods, devices and systems for use in performing in vitro cell rolling assays.
- cell adhesion molecules participate in a wide range of important physiological functions, including wound healing, inflammation and cancer metastasis.
- Some examples of these molecules include selectins and integrins which mediate the rolling and subsequent immobilization of white blood cells along the endothelial lining of blood vessel, thus allowing them to migrate out of the blood vessel and toward the target tissue.
- Cell rolling assays are designed to mimic in vitro the rolling phenomenon in vivo, to create a more effective model for use in screening potential effectors of that phenomenon. See, e.g., Lawrence et al., J.
- the assay is performed by flowing a suspension of cells over a surface upon which ligands are immobilized, and observing the numbers of firmly attached and or rolling cells on that surface as well as the velocity of the rolling cells.
- the present invention employs the microfluidic systems described herein, in the performance of these assay types.
- the cell suspension bearing an appropriate reference label is introduced into a channel in which an appropriate ligand of interest is immobilized on the inner surface.
- Immobilization of ligands on the interior surface of channels is optionally accomplished by covalently attaching the ligands to the surface or by adsorbing the ligands on the surface.
- Covalent attachment of ligands to surfaces of solid substrates has been described in the art. See, e.g., Sundberg, et al., J. Am. Chem. Soc. (1995) 117:12050-57.
- the cell suspension is flowed through the channel, i.e., using pressure flow, as described in greater detail below, and the number of cells that are rolling over or firmly attached to the interior surface of the channel is monitored using an appropriate detection system.
- cells are pulsed through the channel to facilitate their monitoring.
- video imaging system images and identifies the cells as they enter the imaged area, and tracks the cells path through the field, determining their relative velocity.
- point detection systems e.g., as described herein, are used which detect cells at two separate points in the channel, and determine their relative velocity. In the latter case, it is generally desirable to provide the cells in suspension that is sufficiently dilute so as to permit correlation between the two detectors.
- cells may be coded with mixtures of different, distinguishable labels to permit the correlation among cells between points.
- coded cells optionally include wide varieties of different labels, or alternatively, include a set of two, three, four, five, six, seven or eight different labels at varying relative levels, where the profile of the relative levels of labels identifies the different cells.
- test compounds are introduced into a channel, e.g., via an external sample accessing capillary (e.g., an electrokinetic injector or other capillary element) where they contact the suspension of cells.
- the cell suspension is then assayed for rolling or firmly attached cells, and the effect of the test compound, if any, on the cell rolling or binding is determined as compared to the control, e.g., in the absence of the test compound.
- the methods and systems of the present invention are used to assay cellular expression functions, and particularly, for the effect of test compounds on such cellular expression.
- Such assays are generally utilized in screening for effectors of given biological processes, which effectors target those functions at the gene expression level.
- the function label is indicative of the level of gene expression, for a particular gene of interest.
- Gene expression levels are typically assayed by quantifying the level of gene product from the gene of interest, e.g., the amount of protein produced by the cells.
- Alternate methods of gene expression analysis examine the amount of RNA transcribed from the gene of interest.
- such assays involve the use of a nucleic acid hybridization assay to identify a pattern of RNA transcription following an activating event.
- the function label is typically provided that is expressed by the cells during the expression function.
- chimeric reporter systems are optionally employed as function labels or indicators of gene expression.
- Chimeric reporter systems typically incorporate a heterogeneous reporter system integrated into the coding sequence of the gene of interest. The expression of the gene of interest is then accompanied by the expression of the reporter, which is then detected.
- a receptor may be a fusion between the product of the gene of interest and heterologous protein, e.g., an enzyme whose activity is readily assayable, or an otherwise detectable protein, e.g., luciferase, aequo ⁇ n, green fluorescent protein (GFP), ⁇ -galactosidase, alkaline phosphatase, or the like.
- the expressed reporter is then detected and compared with the level of reference label, to provide a quantitative determination of expression levels on a per cell basis.
- Expression of gene products to a detectable level can require varying amounts of time, e.g., several minutes to hours Accordingly, the assay time is va ⁇ ed to allow such expression. As noted herein, such va ⁇ ation is generally accomplished by slowing the flow rates of the cell suspension through a channel and/or lengthening the channel.
- the function label is provided as an element of a binding molecule that specifically associates with the downstream indicator of gene expression, e.g., an expressed protein, wherein the binding of the binding molecule (bea ⁇ ng the function label) to the gene product of interest produces a detectable property within the cell, e.g., as desc ⁇ bed with reference to the binding assays, above.
- the assay methods are then earned out in the same manner as desc ⁇ bed with reference to the binding functions, desc ⁇ bed above.
- the binding molecule optionally includes an antibody specific for the gene product, or a specific binding partner, where the expressed protein is a member of a binding pair, e.g., a receptor or ligand.
- cells are flowed through the channel of the system, and preferably, through multiple parallel channels of the system, and contacted with surfaces of the channel(s) that cause them to adhere.
- Test compounds are then introduced into the channel(s) and allowed to flow over the adhered cells, e.g., for from 5 to 60 minutes. Any effects of these test compounds on the level of function label, and therefore, gene expression, is determined in the channel(s), and compared to the level of reference label.
- the compa ⁇ son then allows quantification of the level of expression on a per cell basis
- the reaction channel is provided such that the travel time of the cells from the point of test compound addition to detection is sufficient to permit approp ⁇ ate expression analysis
- tortuous channels, e g serpentine channels, and the like are used to extend channel lengths to expand the travel time Alternatively or additionally, flow rates are substantially reduced to increase this travel time
- test compound refers to the collection of compounds that are to be screened for their ability to affect a particular biochemical system
- Test compounds optionally include a wide va ⁇ ety of different compounds, including chemical compounds, mixtures of chemical compounds, e g , polysaccha ⁇ des small organic or inorganic molecules, biological macromolecules, e g , peptides, proteins, nucleic acids, or an extract made from biological mate ⁇ als such as bacte ⁇ a, plants, fungi, or animal cells or tissues, naturally occur ⁇ ng or synthetic compositions
- the test compounds may be provided, e.g., injected, free in solution, or may be attached to a earner, or a solid support, e g , beads.
- suitable solid supports may be employed for immobilization of the test compounds
- suitable solid supports include agarose, cellulose, dextran (commercially available as, e.g , Sephadex®, Sepharose®, etc ), carboxymethyl cellulose, polystyrene, polyethylene glycol (PEG), filter paper, nitrocellulose, ion exchange resins, plastic films, glass beads, polyaminemethylvinylether maleic acid copolymer, amino acid copolymer, ethylene-maleic acid copolymer, nylon, silk, etc.
- test compounds may be screened individually, or in groups Group screening is particularly useful where hit rates for effective test compounds are expected to be low such that one would not expect more than one positive result for a given group
- group screening is optionally used where the effects of different test compounds are differentially detected in a single system, e.g , through electrophoretic separation of the effects, or differential labeling which enables separate detection
- vast hbra ⁇ es of test compounds are separately tested for potential effects on different cellular functions
- large bra ⁇ es of chemical compounds prepared using combinato ⁇ al synthesis techniques are typically employed as test compounds in high-throughput screening applications, to identify any such compounds that may have pharmacologically beneficial activities.
- test compounds include large bra ⁇ es of naturally occurnng mate ⁇ als or compounds, hbra ⁇ es of genetic mate ⁇ al, protein fragments,
- test compounds are separately introduced into the assay systems desc ⁇ bed herein
- the relative level of a particular cellular function is then assessed in the presence of the test compound, and this relative level of function is then compared to a control system, which lacks an introduced test compound Increases or decreases in relative cellular function are indicative that the test compound is an enhancer or an inhibitor of the particular cellular function, respectively
- the present invention also provides systems and devices used to practice the above-desc ⁇ bed methods.
- the system includes a channel along which is flowed a suspension of cells or other particles, and cell focusing means as noted above (laminar flow focusing channels, density gradient layers, or both).
- a source of different test compounds is optionally linked to the channel, for introducing the different test compounds into the channel whereupon they are contacted with, e.g., the cells.
- One or more detectors are also provided in sensory communication with the channel, e.g., for detecting and quantifying both the level of reference label and the level of function label present on the cells.
- sensory communication refers to onentation of the detector such that it is capable of obtaining an approp ⁇ ate signal from the point of interest
- sensory communication provides a detector o ⁇ ented such that it is capable of receiving an optical signal from a channel of a microfluidic device.
- Such detection is optionally direct, or includes an intervening optical pathway, e.g., lenses, fiber optics, etc
- an intervening optical pathway e.g., lenses, fiber optics, etc
- Such sensory communication typically requires a sensor component disposed in contact with the fluid mate ⁇ al within the channel
- the detector(s) is/are operably linked to a processor, e.g., a computer, for recording the detected signals, and providing a report of relative activity of the cells that are being assayed.
- the computer also typically includes appropriate programming for determining whether one assay, e.g., a first screening assay, shows greater or lesser cellular function than another assay, e.g., a control.
- Detector systems optionally includes one or more different detector elements, and are selected to detect relevant labels present in the cells.
- the detector typically includes a dual wavelength fluorescent detector.
- This detector typically includes a light source.
- Appropriate light sources typically vary depending upon the type of detection being employed. For example, in some cases broad spectrum illumination is desirable while in other cases, a narrower spectrum illumination is desired.
- the light source is a coherent light source, such as a laser, or laser diode, although other light sources, such as LEDs, lamps or other available light sources are also optionally employed.
- excitation light e.g., light of appropriate wavelength to excite labels
- an analysis channel e.g., disposed in a microfluidic device
- an optical train that includes optional lens, beam splitters, and objective lenses
- electrokinetic material transport systems are used to direct one or more of the flow of cell suspensions, the injection of test compounds, and other material movement parameters.
- the overall system used in performing the assay will typically include an appropriate controller and interface for controlling such electrokinetic material transport.
- transport systems include one or more electrical power supplies that are operably coupled to the termini of the channels in a microfluidic device, e.g., as described in greater detail below.
- connection of the power supply(ies) with the channels is typically accomplished via electrodes placed into reservoirs at the termini of the channels, which electrodes are coupled to the power supply(ies).
- the power supply(ies) then deliver(s) appropriate voltage levels to the various electrodes to yield a desired flow pattern within the channels of the device, e.g., flowing the cell suspension and periodically injecting a test compound.
- the power supply is typically linked to an appropriately programmed computer which directs the application of voltages in accordance with a user selected flow profile
- Microfluidic devices and assay components which are optionally adapted to the present invention are desc ⁇ bed in va ⁇ ous PCT applications and issued U.S. Patents, such as, U.S. Patent Nos. 5,699,157 (J Wallace Parce) issued 12/16/97, 5,779,868 (J Wallace Parce et al.) issued 07/14/98, 5,800,690 (Calvin Y.H. Chow et al.) issued 09/01/98, 5,842,787 (Anne R. Kopf-Sill et al.) issued 12/01/98, 5,852,495 (J.
- the assays of the present invention are earned out within fluidic channels, along which the cell suspensions and or other particles are flowed.
- the channels may simply be present in a capillary tube, e.g., a glass, fused silica, quartz or plastic capillary.
- the capillary channel is fluidly coupled to a source of the suspension of cells or other particles, which are then flowed along the capillary channel.
- the channel is integrated into the body structure of a microfluidic device.
- microfluidic generally refers to one or more fluid passages, chambers or conduits which have at least one internal cross-sectional dimension, e.g., depth, width, length, diameter, etc., that is less than 500 ⁇ m, and typically between about 0.1 ⁇ m and about 500 ⁇ m
- the microscale channels or chambers preferably have at least one cross-sectional dimension between about 0 1 ⁇ m and 200 ⁇ m, more preferably between about 0 1 ⁇ m and 100 ⁇ m, and often between about 0 1 ⁇ m and 50 ⁇ m
- the microfluidic devices or systems prepared in accordance with the present invention typically include at least one microscale channel, usually at least two intersecting microscale channels, and often, three or more intersecting channels disposed within a single body structure Channel intersections may exist in a number of formats, including cross intersections, "Y" or "T” intersections, or any number of other structures, whereby two channels are in fluid communication
- the body structure of the microfluidic devices, desc ⁇ bed herein, typically comp ⁇ ses an aggregation of two or more separate layers which when appropnately mated or joined together, form the microfluidic device of the invention, e.g., containing the channels and/or chambers desc ⁇ bed herein
- the microfluidic devices desc ⁇ bed herein will comp ⁇ se a top portion, a bottom portion, and an inte ⁇ or portion, wherein the inte ⁇ or portion substantially defines the channels and chambers of the device
- the bottom portion of the device compnses a solid substrate that is substantially planar in structure, and which has at least one substantially flat upper surface.
- a va ⁇ ety of substrate mate ⁇ als may be employed as the bottom portion
- substrate matenals will be selected based upon their compatibility with known microfab ⁇ cation techniques, e.g., photolithography, wet chemical etching, laser ablation, air abrasion techniques, injection molding, embossing, and other techniques
- the substrate mate ⁇ als are also generally selected for their compatibility with the full range of conditions to which the microfluidic devices are typically exposed, including extremes of pH, temperature, salt concentration, and application of elect ⁇ c fields
- the substrate mate ⁇ al optionally includes matenals normally associated with the semiconductor industry in which such microfab ⁇ cation techniques are regularly employed, including, e.g , silica based substrates, such as glass, quartz, silicon or polysi con, as well as other substrate maten
- the substrate mate ⁇ als will comp ⁇ se polyme ⁇ c mate ⁇ als, e.g., plastics, such as polymethylmethacrylate (PMMA), polycarbonate, polytetrafluoroethylene (TEFLONTM), polyv ylchlo ⁇ de (PVC), polydimethylsiloxane (PDMS), polysulfone, polystyrene, polymethylpentene, polypropylene, polyethylene, polyviny dine fluonde, ABS (acrylomtnle-butadiene- styrene copolymer), and the like
- plastics such as polymethylmethacrylate (PMMA), polycarbonate, polytetrafluoroethylene (TEFLONTM), polyv ylchlo ⁇ de (PVC), polydimethylsiloxane (PDMS), polysulfone, polystyrene, polymethylpentene, polypropylene, polyethylene, polyviny dine fluonde, ABS (acrylomtn
- polyme ⁇ c substrate mate ⁇ als are preferred for their ease of manufacture, low cost and disposability, as well as their general inertness to most extreme reaction conditions.
- these polyme ⁇ c mate ⁇ als optionally include treated surfaces, e.g., de ⁇ vatized or coated surfaces, to enhance their utility in the microfluidic system, e.g., provide enhanced fluid direction, e.g., as desc ⁇ bed in U.S. Patent Application Se ⁇ al No. 08/843,212, filed Apnl 14, 1997, and which is incorporated herein by reference in its entirety for all purposes.
- the channels and/or chambers of the microfluidic devices are typically fab ⁇ cated into the upper surface of the bottom substrate or portion of the device, as microscale grooves or indentations, using the above desc ⁇ bed microfabncation techniques.
- the top portion or substrate also comp ⁇ ses a first planar surface, and a second surface opposite the first planar surface.
- the top portion also includes a plurality of apertures, holes or ports disposed therethrough, e.g., from the first planar surface to the second surface opposite the first planar surface.
- the first planar surface of the top substrate is then mated, e.g., placed into contact with, and bonded to the planar surface of the bottom substrate, cove ⁇ ng and sealing the grooves and/or indentations in the surface of the bottom substrate, to form the channels and/or chambers (I e., the intenor portion) of the device at the interface of these two components
- Bonding of substrates is typically earned out by any of a number of different methods, e.g., thermal bonding, solvent bonding, ultrasonic welding, and the like.
- the holes in the top portion of the device are o ⁇ ented such that they are in communication with at least one of the channels and/or chambers formed in the inte ⁇ or portion of the device from the grooves or indentations in the bottom substrate
- these holes function as reservoirs for facilitating fluid or mate ⁇ al introduction into the channels or chambers of the inte ⁇ or portion of the device, as well as providing ports at which electrodes may be placed into contact with fluids within the device, allowing application of elect ⁇ c fields along the channels of the device to control and direct fluid transport within the device
- extensions are provided over these reservoirs to allow for increased fluid volumes, permitting longer running assays, and better controlling fluid flow parameters, e.g., hydrostatic pressures.
- Examples of methods and apparatuses for providing such extensions are descnbed in, e.g., Dubrow et al , "Microfluidic Devices and Systems Incorporating Cover Layers," WO 99/43432, published September 2, 1999, which are incorporated herein by reference in their entirety for all purposes
- These devices are optionally coupled to other sample introduction ports, e.g., one or more pipettor or capillary elements (e.g., 1, 2, 3, 4, 6, 8, 10, 12, or more elements) which senally introduce multiple samples, e.g., from the wells of a microwell plate.
- sample introduction ports e.g., one or more pipettor or capillary elements (e.g., 1, 2, 3, 4, 6, 8, 10, 12, or more elements) which senally introduce multiple samples, e.g., from the wells of a microwell plate.
- both reservoirs in the upper surface and external capillary elements are present in a single device.
- the devices include only one or more capillar
- the sources of reagents, samples e.g., cells, microbeads, DNA or other molecules, etc.
- buffers, and other mate ⁇ als are optionally fluidly coupled to the microchannels in any of a va ⁇ ety of ways.
- those systems comp ⁇ sing sources of matenals set forth m Knapp et al., "Closed Loop Biochemical Analyzers” (WO 98/45481 ; PCT/US98/06723) and U.S. Pat. No. 5,942,443, issued August 24, 1999, entitled "High Throughput Screening Assay Systems in Microscale Fluidic Devices" to J. Wallace Parce et al.
- one or more capillary or pipettor elements i.e., an element that includes, e.g., a channel in which components are optionally moved from a source to a microscale element such as a second channel or reservoir
- the source is optionally internal or external to a microfluidic device that includes the pipettor or capillary element
- Example sources include microwell plates, membranes or other solid substrates compnsing lyophilized components, wells or reservoirs in the body of the microscale device itself and others
- one or more capillary elements are used to draw cell or other samples from microwell plates into the body structure of the device
- the channel disposed in the capillary element typically includes a diameter in the range of about 1 ⁇
- the microfluidic devices will include an optical detection window disposed across one or more channels and/or chambers of the device
- Optical detection windows are typically transparent such that they are capable of transmitting an optical signal from the channel/chamber over which they are disposed
- Optical detection windows are optionally merely a region of a transparent cover layer, e.g., where the cover layer is glass or quartz, or a transparent polymer mate ⁇ al, e.g , PMMA, polycarbonate, etc
- transparent detection windows fab ⁇ cated from the above mate ⁇ als are optionally separately manufactured into the device
- inte ⁇ or surfaces of the channels with an approp ⁇ ate treatment to prevent the adhesion of cells or other particles to that surface
- some cell types often have a tendency to stick to the channel surfaces, interfenng with the flowing of cells through the channels
- charge masking coatings such as polyols (e g., polyvmylalcohol (PVA)), polyethyleneimme (PEI), polyethylene glycol (PEG), polyacrylamides (e.g., polyacrylamide, polymethylacryalamide, polydimethacrylamide, and the
- covalent surface treatments are also optionally used to prevent surface adhesion of cells, such as silanization (e.g., using dimethyl or dichlorosilane) of glass or plastic surfaces.
- silanization e.g., using dimethyl or dichlorosilane
- Other surface treatments are generally described, with reference to device fabrication techniques, above.
- a pressure differential is used to flow the suspension of cells along a channel.
- Application of a pressure differential along a channel is carried out by a number of means.
- the cell suspension is deposited in a reservoir at one end of a channel and at a sufficient volume or depth, that the cell suspension creates a hydrostatic pressure differential along the length of the channel, e.g., by virtue of its having greater depth than a reservoir at an opposite terminus of the channel.
- the hydrostatic pressure then causes the cell suspension to flow along the length of the channel.
- the reservoir volume is quite large in comparison to the volume or flow through rate of the channel, e.g., 10 ⁇ l reservoirs, vs. 1000 ⁇ m 2 channel cross- section.
- the flow rate of the cell suspension will remain substantially constant, as the volume of the reservoir, and thus, the hydrostatic pressure changes very slowly.
- Applied pressure is then readily varied to yield different cell suspension flow rates through the channel.
- varying the flow rate of the cell suspension is optionally used to vary the incubation time of the cells with the test compound.
- channel lengths, detection points, or test compound introduction points are varied in fabrication of the devices, to vary incubation times.
- the cell suspension is optionally flowed by applying a pressure differential across the length of a channel
- a pressure source positive or negative
- the pressure source is optionally pneumatic, e g , a pressu ⁇ zed gas, or alternatively is a positive displacement mechanism, i.e., a plunger fitted into a cell suspension reservoir, for forcing the cell suspension through the analysis channel
- a vacuum source is applied to a reservoir at the opposite end of the channel to draw the suspension through the channel
- Pressure or vacuum sources are optionally supplied external to the device or system, e.g., external vacuum or pressure pumps sealably fitted to the inlet or outlet
- cells are initially flowed under pressure, but focused using alternative fluid direction components, such as an electrokinetic force modulator. While electrokinetic forces typically produce substantially uniform fluid flow in microchannels, they tend to disrupt cellular membranes Thus, the use of electrokinetic motive forces is typically limited to focusing pressure -based cellular flows, which as discussed have non-uniform flow velocities
- Electrokinetic transport systems typically utilize electnc fields applied along the length of channels that have a surface potential or charge associated therewith When fluid is introduced into the channel, the charged groups on the inner surface of the channel ionize, creating locally concentrated levels of ions near the fluid surface interface. Under an elect ⁇ c field, this charged sheath migrates toward the cathode or anode (depending upon whether the sheath compnses positive or negative ions) and pulls the encompassed fluid along with it, resulting in bulk fluid flow This flow of fluid is generally termed electroosmotic flow Where the fluid includes a cell or other particle suspension, those components are also pulled along A more detailed descnption of controlled electrokinetic matenal transport systems in microfluidic systems is desc ⁇ bed in published International Patent Application No WO 96/04547, which is incorporated herein by reference
- Hydrostatic, wicking and capillary forces are also optionally used to provide for fluid flow See, e g , "Method and Apparatus for Continuous Liquid Flow in Microscale Channels Using Pressure Injection, Wick-ing and Electrokinetic
- flow of the cell suspension and/or other particles is d ⁇ ven by mertial forces
- channels are optionally disposed in a substrate that has the conformation of a rotor, with channels extending radially outward from the center of the rotor
- the cell suspension is deposited in a reservoir that is located at the inte ⁇ or portion of the rotor and is fluidly connected to the channels Dunng rotation of the rotor, the cent ⁇ petal force on the cell suspension forces the cell suspension through the channels, outward toward the edge of the rotor
- Multiple channels are typically provided in the rotor to perform multiple different analyses. Detection of the function and reference labels is then earned out by placing a detector under the spinning rotor and detecting the signal as a channel passes over the detector.
- Test compound reservoirs are optionally provided in the rotor, in fluid communication with one or more channels, such that the rotation of the rotor also forces the test compounds into the one or more channels
- single body structures are optionally provided with multiple parallel channels coupled to multiple sample accessing capilla ⁇ es that are positioned to sample multiple samples at a time from sample branes, e.g , multiwell plates
- these capillanes are generally spaced at regular distances that correspond with the spacing of wells in multiwell plates, e.g , 9 mm centers for 96 well plates, 4 5 mm for 384 well plates, and 2.25 mm for 1536 well plates
- the present invention is further illustrated with reference to the following non-limiting examples.
- TUNEL ASSAY AND ANNEXIN-V ASSAY FOR APOPTOSIS DETECTION A TUNEL assay (TdT (Terminal deoxynucleotidyl transferase)- mediated dUTP Nick End Labeling) was used to measure cellular apoptosis in accordance with the above-described methods and systems.
- TdT Terminal deoxynucleotidyl transferase
- U937 cells were treated with Campthotecin to induce apoptosis. The cells were then harvested and fixed with 4% formaldehyde and stored in 80% ethanol at +4°C until labeling was performed.
- the cells were rehydrated in TBS buffer. They were then treated with 20 ⁇ g/ml of proteinase K for 5 minutes and resuspended in equilibration buffer. The cells were incubated in a working TdT labeling reaction mixture from Oncogene Research Products containing TdtT enzyme and FragEL TdT labeling reaction mix. The cells were resuspended in TBS and then counterstained with a DNA dye (SYTO®-62 DNA dye at 1 ⁇ M for 10 minutes RT) to obtain a total cell count. After washing the cells in TBS, they were resuspended in Hanks' Balanced
- Figure 4 illustrates a control analysis, e.g., U937 cells not treated to induce apoptosis.
- the bottom line corresponds to the SYTO®-62, which indicates the mere presence of cells, whereas the top line corresponds to the fluorescein end labeled nucleic acids.
- Apoptotic cells would yield a peak on both the upper and lower lines, indicating the presence of an apoptotic cell.
- there are substantially no discernible peaks in the upper line indicating a lack of apoptosis in the control.
- Figure 5 represents U937 cells treated with Campthotecin to induce apoptosis. As can be seen, corresponding peaks are seen on both the lower and upper lines, indicating the presence of apoptotic cells.
- Annexin-V assay change in the outer membrane of apoptotic cells is detected
- a membrane component, phosphatidylse ⁇ ne (PS) is translocated to the outer layer Annexin-V binds to PS and is conjugated to biotin to allow secondary reactions to fluorescently labeled Streptavidin for detection.
- U937 cells were treated with Campthotecin to induce apoptosis The cells were harvested and washed m phosphate buffered saline (PBS).
- PBS m phosphate buffered saline
- HEPES buffer solution contained lOmM HEPES, pH 7.4; 140 mM NaCl, and a 5 mM CaC
- the cells were washed and resuspended m HEPES buffer with 8.5% sucrose and loaded in a microfluidic device for analysis Fluorescence was detected using excitation at 488 nm and 635 nm, and emission was read at 525 nm and 682 nm.
- Figure 6 indicates analysis of U937 cells that were not treated to induce apoptosis.
- the bottom line indicates live cell count (Calcem), while the top line indicates the presence of apoptotic cells (Annex ⁇ n-V-Cy5).
- Figure 7 shows an analysis of the same cells treated with Campthotecin to induce apoptosis.
- the top trace includes a much greater number of peaks representing apoptotic cells, and particularly as a percentage of total cells in the analysis, e.g., as compared to the lower line
- Figure 8 shows results from a TUNEL assay with HL-60 cells treated with Campthotecin for 6 hours to induce apoptosis.
- the bottom line traces the total cell count.
- the top line traces apoptotic cells labeled at DNA damage points. In this case, almost all cells had sustained apoptotic DNA damage.
- Figure 9 shows results from a TUNEL assay HL-60 cells (not treated for apoptosis) were used as control cells.
- the bottom trace is for SYTO®-62 indicating total cell count.
- the top trace is for Fluorescein labeled nucleotide which signifies the presence of apoptosis related DNA damage.
- Figures 10 and 11 shows results from TUNEL assays from Figures 8 and 9 analyzed using appropnate software. Data is presented as scatter plot format in Figure 10. In Figure 11, data is represented in bar graph format. Additional data for different time points and two other cell lines is included.
- Figure 12 shows and Annexin-V assay. HL60 cells were treated with Campothotecin for four hours to induce apoptosis. The bottom trace indicates live cell count (Calcein). The top trace indicates Annexin-V-Cy5 labeling. Cells labeled only for Calcein are live cells and not apoptotic. In this case, almost all cells are apoptotic.
- Figure 13 shows an Annexin-V assay.
- HL-60 cells (not treated for apoptosis) are control cells.
- the bottom trace indicates live cell count.
- the top trace indicates Annexin-V-Cy5 labeling.
- Cells labeled with both dyes are apoptotic.
- Cells labeled only for Annexin-CY5 are dead cells. In this case, only a few cells were apoptotic.
- Figures 14 and 15 show data analysis of figures 12 and 13. Data is presented in scatter plot format in Figure 14. In Figure 15, data is represented in bar graph format. Additional data for different time points and two other cell lines is included.
- Figure 17 depicts a chip employing a channel geometry that was used to conduct fluorescence population experiments to confirm the feasibility of the device as a microfluidic flow cytometer.
- the experiment entailed comparing microfluidic hydrodynamic focusing data obtained by flowing fluorescently-labeled calibration beads (Quantum 26 Fluorescein Microbeads Standards B-111698 from Flow Cytometry Standards Corp.) through the microfluidic flow cytometer (both focused and unfocused) with data provided in a certificate of calibration that accompanied the beads.
- Flow Cytometry Standards Corp. obtained the calibration data by flowing the same type of bead through a traditional flow cytometer.
- Figure 18 is a histogram showing the distribution of results obtained in the fluorescence intensity population experiment conducted utilizing hydrodynamic focusing in the microfluidic flow cytometer.
- Figures 19 and 20 are histograms showing the distribution of results obtained in the fluorescence intensity population experiment conducted, in the same microfluidic flow cytometer, in the absence of hydrodynamic focusing.
- the focused beads resolve into a more uniform fluorescence intensity population than the unfocused beads which are more widely dist ⁇ aded
- the focused beads are comparable to results achievable using traditional flow cytometers, which typically include a coefficient of va ⁇ ation (%CV) of about 6%, according to the calibration data provided by Flow Cytometry Standards Corp
- %CV coefficient of va ⁇ ation
- the calculated %CV for the focused beads in the microfluidic system was about 6 8%, whereas that calculated for the unfocused beads was only about 28 8%
- an acceptable %CV is less than 15%, which further demonstrates the feasibility of the device, e g , as a flow cytometer
- Figures 25A, B, and C are histograms showing the dist ⁇ bution of results obtained in resolution expe ⁇ ments using va ⁇ ous microbead to buffer concentrations, namely, 1 1, 1 3, and 1 7, respectively.
- the expe ⁇ ments were conducted using an Agilent bioanalyzer microfluidic system to determine whether microbead doublet populations could be resolved As shown, even at the highest microbead concentration, where the largest population of doublets was expected, significant resolution of the two populations was observed with a %CV of about 6 7 % (FIG.
- a microfluidic system containing at least a first substrate and having a first channel and a second channel intersecting the first channel, at least one of the channels having at least one cross-sectional dimension in a range from 0 1 to 500 ⁇ m, in order to test the effect of each of a plurality of test compounds on a biochemical system compnsing one or more focused cells or particles
- a microfluidic system as desc ⁇ bed herein, wherein a biochemical system flows through one of said channels substantially continuously, providing for, e g , sequential testing of a plurality of test compounds
- microfluidic device as desc ⁇ bed herein to modulate reactions within microchannels or microchambers
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Analytical Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Physics & Mathematics (AREA)
- Molecular Biology (AREA)
- Dispersion Chemistry (AREA)
- Pathology (AREA)
- Biochemistry (AREA)
- General Physics & Mathematics (AREA)
- Immunology (AREA)
- Clinical Laboratory Science (AREA)
- Hematology (AREA)
- Electrochemistry (AREA)
- Organic Chemistry (AREA)
- Fluid Mechanics (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
Description
Claims
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU50158/00A AU770678B2 (en) | 1999-05-17 | 2000-05-11 | Focusing of microparticles in microfluidic systems |
CA002373347A CA2373347A1 (en) | 1999-05-17 | 2000-05-11 | Focusing of microparticles in microfluidic systems |
EP00932435.1A EP1179087B1 (en) | 1999-05-17 | 2000-05-11 | Focusing of microparticles in microfluidic systems |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US13447299P | 1999-05-17 | 1999-05-17 | |
US60/134,472 | 1999-05-17 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2000070080A1 true WO2000070080A1 (en) | 2000-11-23 |
Family
ID=22463547
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2000/013294 WO2000070080A1 (en) | 1999-05-17 | 2000-05-11 | Focusing of microparticles in microfluidic systems |
Country Status (5)
Country | Link |
---|---|
US (1) | US6506609B1 (en) |
EP (1) | EP1179087B1 (en) |
AU (1) | AU770678B2 (en) |
CA (1) | CA2373347A1 (en) |
WO (1) | WO2000070080A1 (en) |
Cited By (83)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6576194B1 (en) * | 1998-05-18 | 2003-06-10 | University Of Washington | Sheath flow assembly |
WO2004002627A2 (en) * | 2002-06-28 | 2004-01-08 | President And Fellows Of Harvard College | Method and apparatus for fluid dispersion |
GB2392397A (en) * | 2002-08-30 | 2004-03-03 | Intel Corp | Fluid focussing in a microfluidic device |
DE10318864B3 (en) * | 2003-04-25 | 2004-09-23 | Siemens Ag | Micro-fluidic valve, for controlled introduction of fluid into channel during capillary electrophoresis, combines electrical potential gradient with curvature inducing Coanda effect |
WO2005042137A2 (en) | 2003-10-30 | 2005-05-12 | Cytonome, Inc. | Multilayer hydrodynamic sheath flow structure |
WO2007042126A1 (en) * | 2005-10-07 | 2007-04-19 | HAHN-SCHICKARD-GESELLSCHAFT FÜR ANGEWANDTE FORSCHUNG e-V. | Apparatus and method for producing a mixture of two phases that are insoluble in each other |
US7247274B1 (en) | 2001-11-13 | 2007-07-24 | Caliper Technologies Corp. | Prevention of precipitate blockage in microfluidic channels |
WO2009061392A1 (en) * | 2007-11-05 | 2009-05-14 | President And Fellows Of Harvard College | Forming gel structures using microfluidic channels |
US7569788B2 (en) | 2002-04-17 | 2009-08-04 | Cytonome/St, Llc | Method and apparatus for sorting particles |
US7584857B2 (en) | 2002-04-17 | 2009-09-08 | Cytonome/St, Llc | Method and apparatus for sorting particles |
AU2003228630B2 (en) * | 2002-04-17 | 2009-10-22 | Cytonome/St, Llc | Method and apparatus for sorting particles |
EP2115471A1 (en) * | 2006-12-19 | 2009-11-11 | Fio Corporation | Microfluidic system and method to test for target molecules in a biological sample |
FR2936316A1 (en) * | 2008-09-25 | 2010-03-26 | Etat Francais Dga | DEVICE FOR SELECTIVE PRECONCENTRATION / DETECTION OF CHARGED ANALYTES CONTAINED IN AN ELECTROLYTE AND ASSOCIATED METHOD. |
US7776927B2 (en) | 2007-03-28 | 2010-08-17 | President And Fellows Of Harvard College | Emulsions and techniques for formation |
US8216852B2 (en) | 2001-07-27 | 2012-07-10 | Caliper Life Sciences, Inc. | Channel cross-section geometry to manipulate dispersion rates |
WO2013007028A1 (en) * | 2011-07-14 | 2013-01-17 | 深圳西德赛科技有限公司 | Method and system for self-calibrating microfluidic chip-based detection system |
AU2011205167B2 (en) * | 2003-10-30 | 2013-01-24 | Cytonome/St, Llc | Multilayer hydrodynamic sheath flow structure |
US8361716B2 (en) | 2008-10-03 | 2013-01-29 | Pathogenetix, Inc. | Focusing chamber |
US8518705B2 (en) | 1999-08-13 | 2013-08-27 | Pathogenetix, Inc. | Methods and apparatuses for stretching polymers |
US8623295B2 (en) | 2002-04-17 | 2014-01-07 | Cytonome/St, Llc | Microfluidic system including a bubble valve for regulating fluid flow through a microchannel |
US8685708B2 (en) | 2012-04-18 | 2014-04-01 | Pathogenetix, Inc. | Device for preparing a sample |
US8841071B2 (en) | 2011-06-02 | 2014-09-23 | Raindance Technologies, Inc. | Sample multiplexing |
US8871444B2 (en) | 2004-10-08 | 2014-10-28 | Medical Research Council | In vitro evolution in microfluidic systems |
US8900811B2 (en) | 2000-11-16 | 2014-12-02 | Caliper Life Sciences, Inc. | Method and apparatus for generating thermal melting curves in a microfluidic device |
US8999636B2 (en) | 2007-01-08 | 2015-04-07 | Toxic Report Llc | Reaction chamber |
US9012390B2 (en) | 2006-08-07 | 2015-04-21 | Raindance Technologies, Inc. | Fluorocarbon emulsion stabilizing surfactants |
US9017623B2 (en) | 2007-02-06 | 2015-04-28 | Raindance Technologies, Inc. | Manipulation of fluids and reactions in microfluidic systems |
US9028776B2 (en) | 2012-04-18 | 2015-05-12 | Toxic Report Llc | Device for stretching a polymer in a fluid sample |
US9039273B2 (en) | 2005-03-04 | 2015-05-26 | President And Fellows Of Harvard College | Method and apparatus for forming multiple emulsions |
US9038919B2 (en) | 2003-04-10 | 2015-05-26 | President And Fellows Of Harvard College | Formation and control of fluidic species |
US9040304B2 (en) | 2003-03-28 | 2015-05-26 | Inguran, Llc | Multi-channel system and methods for sorting particles |
US9068699B2 (en) | 2007-04-19 | 2015-06-30 | Brandeis University | Manipulation of fluids, fluid components and reactions in microfluidic systems |
US9074242B2 (en) | 2010-02-12 | 2015-07-07 | Raindance Technologies, Inc. | Digital analyte analysis |
US9150852B2 (en) | 2011-02-18 | 2015-10-06 | Raindance Technologies, Inc. | Compositions and methods for molecular labeling |
US9238206B2 (en) | 2011-05-23 | 2016-01-19 | President And Fellows Of Harvard College | Control of emulsions, including multiple emulsions |
US9273308B2 (en) | 2006-05-11 | 2016-03-01 | Raindance Technologies, Inc. | Selection of compartmentalized screening method |
US9328344B2 (en) | 2006-01-11 | 2016-05-03 | Raindance Technologies, Inc. | Microfluidic devices and methods of use in the formation and control of nanoreactors |
US9366632B2 (en) | 2010-02-12 | 2016-06-14 | Raindance Technologies, Inc. | Digital analyte analysis |
US9364803B2 (en) | 2011-02-11 | 2016-06-14 | Raindance Technologies, Inc. | Methods for forming mixed droplets |
US9365822B2 (en) | 1997-12-31 | 2016-06-14 | Xy, Llc | System and method for sorting cells |
US9399797B2 (en) | 2010-02-12 | 2016-07-26 | Raindance Technologies, Inc. | Digital analyte analysis |
US9448172B2 (en) | 2003-03-31 | 2016-09-20 | Medical Research Council | Selection by compartmentalised screening |
US9459200B2 (en) | 2008-08-29 | 2016-10-04 | Fio Corporation | Single-use handheld diagnostic test device, and an associated system and method for testing biological and environmental test samples |
US9498759B2 (en) | 2004-10-12 | 2016-11-22 | President And Fellows Of Harvard College | Compartmentalized screening by microfluidic control |
US9562897B2 (en) | 2010-09-30 | 2017-02-07 | Raindance Technologies, Inc. | Sandwich assays in droplets |
US9562837B2 (en) | 2006-05-11 | 2017-02-07 | Raindance Technologies, Inc. | Systems for handling microfludic droplets |
US9588100B2 (en) | 2013-10-30 | 2017-03-07 | Premium Genetics (Uk) Ltd | Microfluidic system and method with focused energy apparatus |
US9695482B2 (en) | 2007-10-12 | 2017-07-04 | Fio Coporation | Flow focusing method and system for forming concentrated volumes of microbeads, and microbeads formed further thereto |
US9792809B2 (en) | 2008-06-25 | 2017-10-17 | Fio Corporation | Bio-threat alert system |
US9789482B2 (en) | 2003-08-27 | 2017-10-17 | President And Fellows Of Harvard College | Methods of introducing a fluid into droplets |
US9805165B2 (en) | 2009-01-13 | 2017-10-31 | Fio Corporation | Handheld diagnostic test device and method for use with an electronic device and a test cartridge in a rapid diagnostic test |
US9839890B2 (en) | 2004-03-31 | 2017-12-12 | National Science Foundation | Compartmentalised combinatorial chemistry by microfluidic control |
US9879221B2 (en) | 2000-11-29 | 2018-01-30 | Xy, Llc | Method of in-vitro fertilization with spermatozoa separated into X-chromosome and Y-chromosome bearing populations |
US9943847B2 (en) | 2002-04-17 | 2018-04-17 | Cytonome/St, Llc | Microfluidic system including a bubble valve for regulating fluid flow through a microchannel |
US10052605B2 (en) | 2003-03-31 | 2018-08-21 | Medical Research Council | Method of synthesis and testing of combinatorial libraries using microcapsules |
US10195571B2 (en) | 2011-07-06 | 2019-02-05 | President And Fellows Of Harvard College | Multiple emulsions and techniques for the formation of multiple emulsions |
US10351905B2 (en) | 2010-02-12 | 2019-07-16 | Bio-Rad Laboratories, Inc. | Digital analyte analysis |
US10520500B2 (en) | 2009-10-09 | 2019-12-31 | Abdeslam El Harrak | Labelled silica-based nanomaterial with enhanced properties and uses thereof |
US10533998B2 (en) | 2008-07-18 | 2020-01-14 | Bio-Rad Laboratories, Inc. | Enzyme quantification |
US10583439B2 (en) | 2013-03-14 | 2020-03-10 | Cytonome/St, Llc | Hydrodynamic focusing apparatus and methods |
US10647981B1 (en) | 2015-09-08 | 2020-05-12 | Bio-Rad Laboratories, Inc. | Nucleic acid library generation methods and compositions |
EP3677336A1 (en) | 2007-09-05 | 2020-07-08 | Caliper Life Sciences Inc. | Microfluidic method and system for enzyme inhibition activity screening |
US10732649B2 (en) | 2004-07-02 | 2020-08-04 | The University Of Chicago | Microfluidic system |
US10816550B2 (en) | 2012-10-15 | 2020-10-27 | Nanocellect Biomedical, Inc. | Systems, apparatus, and methods for sorting particles |
US10837883B2 (en) | 2009-12-23 | 2020-11-17 | Bio-Rad Laboratories, Inc. | Microfluidic systems and methods for reducing the exchange of molecules between droplets |
US10874997B2 (en) | 2009-09-02 | 2020-12-29 | President And Fellows Of Harvard College | Multiple emulsions created using jetting and other techniques |
US10994273B2 (en) | 2004-12-03 | 2021-05-04 | Cytonome/St, Llc | Actuation of parallel microfluidic arrays |
US11174509B2 (en) | 2013-12-12 | 2021-11-16 | Bio-Rad Laboratories, Inc. | Distinguishing rare variations in a nucleic acid sequence from a sample |
US11187224B2 (en) | 2013-07-16 | 2021-11-30 | Abs Global, Inc. | Microfluidic chip |
US11193176B2 (en) | 2013-12-31 | 2021-12-07 | Bio-Rad Laboratories, Inc. | Method for detecting and quantifying latent retroviral RNA species |
US11193879B2 (en) | 2010-11-16 | 2021-12-07 | 1087 Systems, Inc. | Use of vibrational spectroscopy for microfluidic liquid measurement |
US11230695B2 (en) | 2002-09-13 | 2022-01-25 | Xy, Llc | Sperm cell processing and preservation systems |
US11243494B2 (en) | 2002-07-31 | 2022-02-08 | Abs Global, Inc. | Multiple laminar flow-based particle and cellular separation with laser steering |
US11268887B2 (en) | 2009-03-23 | 2022-03-08 | Bio-Rad Laboratories, Inc. | Manipulation of microfluidic droplets |
US11331670B2 (en) | 2018-05-23 | 2022-05-17 | Abs Global, Inc. | Systems and methods for particle focusing in microchannels |
US11415503B2 (en) | 2013-10-30 | 2022-08-16 | Abs Global, Inc. | Microfluidic system and method with focused energy apparatus |
US11511242B2 (en) | 2008-07-18 | 2022-11-29 | Bio-Rad Laboratories, Inc. | Droplet libraries |
US11628439B2 (en) | 2020-01-13 | 2023-04-18 | Abs Global, Inc. | Single-sheath microfluidic chip |
US11889830B2 (en) | 2019-04-18 | 2024-02-06 | Abs Global, Inc. | System and process for continuous addition of cryoprotectant |
US11901041B2 (en) | 2013-10-04 | 2024-02-13 | Bio-Rad Laboratories, Inc. | Digital analysis of nucleic acid modification |
US11898193B2 (en) | 2011-07-20 | 2024-02-13 | Bio-Rad Laboratories, Inc. | Manipulating droplet size |
US11982611B2 (en) | 2017-03-20 | 2024-05-14 | Nanocellect Biomedical, Inc. | Systems, apparatuses, and methods for cell sorting and flow cytometry |
US12038438B2 (en) | 2008-07-18 | 2024-07-16 | Bio-Rad Laboratories, Inc. | Enzyme quantification |
Families Citing this family (122)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6048734A (en) | 1995-09-15 | 2000-04-11 | The Regents Of The University Of Michigan | Thermal microvalves in a fluid flow method |
WO2001051918A1 (en) * | 2000-01-12 | 2001-07-19 | Ut-Battelle, Llc | A microfluidic device and method for focusing, segmenting, and dispensing of a fluid stream |
US7040144B2 (en) * | 2000-02-23 | 2006-05-09 | Caliper Life Sciences, Inc. | Microfluidic viscometer |
IL151122A0 (en) * | 2000-02-23 | 2003-04-10 | Caliper Techn Corp | Multi-reservoir pressure control system |
US6681616B2 (en) * | 2000-02-23 | 2004-01-27 | Caliper Technologies Corp. | Microfluidic viscometer |
US20030186426A1 (en) * | 2000-03-15 | 2003-10-02 | The Regents Of The University Of California | Multichannel flow cell for interacting single optically trapped, DNA molecules with different chemical species |
US6635487B1 (en) * | 2000-05-17 | 2003-10-21 | Caliper Technologies Corp. | Fluorescence standard for use in microfluidic instruments |
US8071051B2 (en) * | 2004-05-14 | 2011-12-06 | Honeywell International Inc. | Portable sample analyzer cartridge |
US6692700B2 (en) | 2001-02-14 | 2004-02-17 | Handylab, Inc. | Heat-reduction methods and systems related to microfluidic devices |
US7829025B2 (en) | 2001-03-28 | 2010-11-09 | Venture Lending & Leasing Iv, Inc. | Systems and methods for thermal actuation of microfluidic devices |
US6852287B2 (en) | 2001-09-12 | 2005-02-08 | Handylab, Inc. | Microfluidic devices having a reduced number of input and output connections |
US7010391B2 (en) | 2001-03-28 | 2006-03-07 | Handylab, Inc. | Methods and systems for control of microfluidic devices |
US8895311B1 (en) | 2001-03-28 | 2014-11-25 | Handylab, Inc. | Methods and systems for control of general purpose microfluidic devices |
US7323140B2 (en) | 2001-03-28 | 2008-01-29 | Handylab, Inc. | Moving microdroplets in a microfluidic device |
CA2463420A1 (en) * | 2001-10-24 | 2003-05-01 | Singulex, Inc. | Methods for detecting genetic haplotypes by interaction with probes |
EP1444338A4 (en) * | 2001-11-15 | 2007-07-04 | Arryx Inc | Sample chip |
US7524462B2 (en) * | 2002-03-29 | 2009-04-28 | Agilent Technologies, Inc. | Capillary flow for a heterogenous assay in a micro-channel environment |
US8241883B2 (en) * | 2002-04-24 | 2012-08-14 | Caliper Life Sciences, Inc. | High throughput mobility shift |
US7118676B2 (en) * | 2003-09-04 | 2006-10-10 | Arryx, Inc. | Multiple laminar flow-based particle and cellular separation with laser steering |
US7699767B2 (en) | 2002-07-31 | 2010-04-20 | Arryx, Inc. | Multiple laminar flow-based particle and cellular separation with laser steering |
EP3229240A1 (en) | 2002-07-31 | 2017-10-11 | Premium Genetics (UK) Limited | System and method of sorting materials using holographic laser steering |
US20040115830A1 (en) * | 2002-09-25 | 2004-06-17 | Igor Touzov | Components for nano-scale Reactor |
EP2359689B1 (en) | 2002-09-27 | 2015-08-26 | The General Hospital Corporation | Microfluidic device for cell separation and use thereof |
WO2004083108A1 (en) * | 2003-03-23 | 2004-09-30 | Gyros Patent Ab | Preloaded microscale devices |
SE0300823D0 (en) | 2003-03-23 | 2003-03-23 | Gyros Ab | Preloaded Microscale Devices |
WO2004094986A2 (en) * | 2003-04-16 | 2004-11-04 | Handylab, Inc. | System and method for electrochemical detection of biological compounds |
US7115230B2 (en) * | 2003-06-26 | 2006-10-03 | Intel Corporation | Hydrodynamic focusing devices |
US7381361B2 (en) * | 2003-06-26 | 2008-06-03 | Intel Corporation | Fabricating structures in micro-fluidic channels based on hydrodynamic focusing |
DE10334164A1 (en) * | 2003-07-26 | 2005-02-17 | Eppendorf Ag | Glass capillary for microinjection and method for making a glass capillary for microinjection |
EP3718635A1 (en) | 2003-07-31 | 2020-10-07 | Handylab, Inc. | Processing particle-containing samples |
US20090088982A1 (en) * | 2003-07-31 | 2009-04-02 | Fukushima Noelle H | Co-detection of single polypeptide and polynucleotide molecules |
US20080021674A1 (en) * | 2003-09-30 | 2008-01-24 | Robert Puskas | Methods for Enhancing the Analysis of Particle Detection |
US20060057597A1 (en) * | 2003-11-12 | 2006-03-16 | California Institute Of Technology | Method and system for processing nanoparticles using a self assembly mechanism to form combined species |
JP3991034B2 (en) * | 2004-01-23 | 2007-10-17 | キヤノン株式会社 | Detection method |
US20050201660A1 (en) * | 2004-03-11 | 2005-09-15 | Grot Annette C. | Apparatus for single nanoparticle detection |
US8852862B2 (en) | 2004-05-03 | 2014-10-07 | Handylab, Inc. | Method for processing polynucleotide-containing samples |
US8470586B2 (en) * | 2004-05-03 | 2013-06-25 | Handylab, Inc. | Processing polynucleotide-containing samples |
JP4412081B2 (en) * | 2004-07-07 | 2010-02-10 | 株式会社日立製作所 | Gas turbine and gas turbine cooling method |
US9040305B2 (en) * | 2004-09-28 | 2015-05-26 | Singulex, Inc. | Method of analysis for determining a specific protein in blood samples using fluorescence spectrometry |
US8685711B2 (en) | 2004-09-28 | 2014-04-01 | Singulex, Inc. | Methods and compositions for highly sensitive detection of molecules |
JP2008514955A (en) * | 2004-09-28 | 2008-05-08 | シンギュレックス・インコーポレイテッド | Sample analysis system and method |
US7572640B2 (en) * | 2004-09-28 | 2009-08-11 | Singulex, Inc. | Method for highly sensitive detection of single protein molecules labeled with fluorescent moieties |
BRPI0518824B1 (en) | 2004-12-03 | 2017-11-28 | Cytonome/St, Llc | "PARTICLE CARTRIDGE FOR PARTICLE PROCESSING AND METHOD OF PROCESSING OF A SAMPLE" |
US7355696B2 (en) | 2005-02-01 | 2008-04-08 | Arryx, Inc | Method and apparatus for sorting cells |
US20070054119A1 (en) * | 2005-03-04 | 2007-03-08 | Piotr Garstecki | Systems and methods of forming particles |
AU2006247739A1 (en) | 2005-05-11 | 2006-11-23 | Vector Tobacco Inc. | Reduced risk tobacco products and methods of making same |
JP4995197B2 (en) * | 2005-07-01 | 2012-08-08 | ハネウェル・インターナショナル・インコーポレーテッド | Molded cartridge with 3D hydrodynamic focusing |
US20070042406A1 (en) * | 2005-07-18 | 2007-02-22 | U.S. Genomics, Inc. | Diffusion mediated clean-up of a target carrier fluid |
EP1904653A4 (en) * | 2005-07-18 | 2010-04-14 | Us Genomics Inc | Microfluidic methods and apparatuses for sample preparation and analysis |
KR100670590B1 (en) * | 2005-10-05 | 2007-01-17 | 주식회사 디지탈바이오테크놀러지 | Microchip with expansion channel and flowcytometer using this microchip |
WO2007044917A2 (en) * | 2005-10-11 | 2007-04-19 | Handylab, Inc. | Polynucleotide sample preparation device |
US8097421B2 (en) * | 2005-12-29 | 2012-01-17 | Intel Corporation | Method for performing a multiplex immunoassay using label disassociation and an integrated substrate |
DE602007009811D1 (en) * | 2006-01-27 | 2010-11-25 | Harvard College | COALESCENCE FLUIDER DROPLET |
CA2571904A1 (en) * | 2006-02-15 | 2007-08-15 | Fio Corporation | System and method of detecting pathogens |
ES2692380T3 (en) | 2006-03-24 | 2018-12-03 | Handylab, Inc. | Method to perform PCR with a cartridge with several tracks |
US10900066B2 (en) | 2006-03-24 | 2021-01-26 | Handylab, Inc. | Microfluidic system for amplifying and detecting polynucleotides in parallel |
US8883490B2 (en) | 2006-03-24 | 2014-11-11 | Handylab, Inc. | Fluorescence detector for microfluidic diagnostic system |
US7998708B2 (en) | 2006-03-24 | 2011-08-16 | Handylab, Inc. | Microfluidic system for amplifying and detecting polynucleotides in parallel |
US11806718B2 (en) | 2006-03-24 | 2023-11-07 | Handylab, Inc. | Fluorescence detector for microfluidic diagnostic system |
US7838250B1 (en) | 2006-04-04 | 2010-11-23 | Singulex, Inc. | Highly sensitive system and methods for analysis of troponin |
CN101438146B (en) | 2006-04-04 | 2014-12-10 | 神谷来克斯公司 | Methods and compositions for highly sensitive analysis of markers and detection of molecules |
CN101454653B (en) * | 2006-05-17 | 2013-01-16 | 卢米尼克斯股份有限公司 | Chip-based flow cytometer type systems for analyzing fluorescently tagged particles |
US20090051372A1 (en) * | 2006-10-30 | 2009-02-26 | Palaniappan Sethu | 3D fluid confined sample stream coulter flow cytometry |
WO2008061165A2 (en) | 2006-11-14 | 2008-05-22 | Handylab, Inc. | Microfluidic cartridge and method of making same |
US8360321B2 (en) | 2007-04-02 | 2013-01-29 | Fio Corporation | System and method of deconvolving multiplexed fluorescence spectral signals generated by quantum dot optical coding technology |
EP2142279A2 (en) | 2007-04-16 | 2010-01-13 | The General Hospital Corporation d/b/a Massachusetts General Hospital | Systems and methods for particle focusing in microchannels |
US8691164B2 (en) * | 2007-04-20 | 2014-04-08 | Celula, Inc. | Cell sorting system and methods |
KR20080110167A (en) * | 2007-06-14 | 2008-12-18 | 삼성전자주식회사 | A apparatus for focusing and detecting particles in a sample and a method of manufacturing the same |
US8597729B2 (en) | 2007-06-22 | 2013-12-03 | Fio Corporation | Systems and methods for manufacturing quantum dot-doped polymer microbeads |
US8551786B2 (en) * | 2007-07-09 | 2013-10-08 | Fio Corporation | Systems and methods for enhancing fluorescent detection of target molecules in a test sample |
WO2009009127A2 (en) * | 2007-07-12 | 2009-01-15 | U.S. Genomics, Inc. | Method and system for transferring and/or concentrating a sample |
US20090136385A1 (en) | 2007-07-13 | 2009-05-28 | Handylab, Inc. | Reagent Tube |
US9186677B2 (en) | 2007-07-13 | 2015-11-17 | Handylab, Inc. | Integrated apparatus for performing nucleic acid extraction and diagnostic testing on multiple biological samples |
US8133671B2 (en) * | 2007-07-13 | 2012-03-13 | Handylab, Inc. | Integrated apparatus for performing nucleic acid extraction and diagnostic testing on multiple biological samples |
US9618139B2 (en) | 2007-07-13 | 2017-04-11 | Handylab, Inc. | Integrated heater and magnetic separator |
USD621060S1 (en) | 2008-07-14 | 2010-08-03 | Handylab, Inc. | Microfluidic cartridge |
WO2009012185A1 (en) | 2007-07-13 | 2009-01-22 | Handylab, Inc. | Polynucleotide capture materials, and methods of using same |
US8105783B2 (en) | 2007-07-13 | 2012-01-31 | Handylab, Inc. | Microfluidic cartridge |
US8287820B2 (en) | 2007-07-13 | 2012-10-16 | Handylab, Inc. | Automated pipetting apparatus having a combined liquid pump and pipette head system |
US8182763B2 (en) | 2007-07-13 | 2012-05-22 | Handylab, Inc. | Rack for sample tubes and reagent holders |
US8016260B2 (en) * | 2007-07-19 | 2011-09-13 | Formulatrix, Inc. | Metering assembly and method of dispensing fluid |
JP2010534322A (en) * | 2007-07-23 | 2010-11-04 | フィオ コーポレイション | Methods and systems for collating, storing, analyzing, and accessing data collected and analyzed for biological and environmental analytes |
US8298496B2 (en) * | 2007-07-23 | 2012-10-30 | Flir Systems, Inc. | Fluidic configuration for flow injection analysis |
CN101842159B (en) * | 2007-08-09 | 2014-09-24 | 赛路拉公司 | Methods and devices for correlated, multi-parameter single cell measurements and recovery of remnant biological material |
CA2709217C (en) | 2007-12-19 | 2021-01-05 | Singulex, Inc. | Scanning analyzer for single molecule detection and methods of use |
US9594071B2 (en) * | 2007-12-21 | 2017-03-14 | Colin G. Hebert | Device and method for laser analysis and separation (LAS) of particles |
US10281385B2 (en) * | 2007-12-21 | 2019-05-07 | The United States Of America, As Represented By The Secretary Of The Navy | Device for laser analysis and separation (LAS) of particles |
CN102016552A (en) * | 2008-03-05 | 2011-04-13 | 神谷来克斯公司 | Methods and compositions for highly sensitive detection of molecules |
FR2931085B1 (en) * | 2008-05-13 | 2011-05-27 | Commissariat Energie Atomique | METHOD OF SORTING PARTICLES OR AMAS FROM PARTICLES IN A FLUID CIRCULATING IN A CHANNEL |
USD618820S1 (en) | 2008-07-11 | 2010-06-29 | Handylab, Inc. | Reagent holder |
USD787087S1 (en) | 2008-07-14 | 2017-05-16 | Handylab, Inc. | Housing |
US20100018584A1 (en) * | 2008-07-28 | 2010-01-28 | Technion Research & Development Foundation Ltd. | Microfluidic system and method for manufacturing the same |
GB2464183A (en) * | 2008-09-19 | 2010-04-14 | Singulex Inc | Sandwich assay |
US8100293B2 (en) * | 2009-01-23 | 2012-01-24 | Formulatrix, Inc. | Microfluidic dispensing assembly |
US20110070581A1 (en) * | 2009-04-27 | 2011-03-24 | Amit Gupta | Separation of Leukocytes |
US20110065101A1 (en) * | 2009-06-04 | 2011-03-17 | Lockheed Martin Corporation | Multiple-sample microfluidic chip for DNA analysis |
WO2010144358A1 (en) * | 2009-06-08 | 2010-12-16 | Singulex, Inc. | Highly sensitive biomarker panels |
US8834807B2 (en) | 2009-08-12 | 2014-09-16 | Caliper Life Sciences, Inc. | Device and method for improving sample injection and stacking |
US8202486B2 (en) * | 2009-08-12 | 2012-06-19 | Caliper Life Sciences, Inc. | Pinching channels for fractionation of fragmented samples |
JP2013525087A (en) * | 2010-03-17 | 2013-06-20 | プレジデント アンド フェロウズ オブ ハーバード カレッジ | Melt emulsification |
US20110301053A1 (en) | 2010-05-06 | 2011-12-08 | Singulex, Inc. | Methods for Diagnosing, Staging, Predicting Risk for Developing and Identifying Treatment Responders for Rheumatoid Arthritis |
AU2011315951B2 (en) | 2010-10-15 | 2015-03-19 | Lockheed Martin Corporation | Micro fluidic optic design |
US8371683B2 (en) | 2010-12-23 | 2013-02-12 | Palo Alto Research Center Incorporated | Particle removal device for ink jet printer |
EP2490005A1 (en) | 2011-02-18 | 2012-08-22 | Koninklijke Philips Electronics N.V. | Microfluidic resistance network and microfluidic device |
EP3709025A1 (en) | 2011-04-15 | 2020-09-16 | Becton, Dickinson and Company | Scanning real-time microfluidic thermocycler and methods for synchronized thermocycling and scanning optical detection |
USD692162S1 (en) | 2011-09-30 | 2013-10-22 | Becton, Dickinson And Company | Single piece reagent holder |
WO2013049706A1 (en) | 2011-09-30 | 2013-04-04 | Becton, Dickinson And Company | Unitized reagent strip |
WO2013067202A1 (en) | 2011-11-04 | 2013-05-10 | Handylab, Inc. | Polynucleotide sample preparation device |
CA2863637C (en) | 2012-02-03 | 2021-10-26 | Becton, Dickinson And Company | External files for distribution of molecular diagnostic tests and determination of compatibility between tests |
US9322054B2 (en) | 2012-02-22 | 2016-04-26 | Lockheed Martin Corporation | Microfluidic cartridge |
US9429500B2 (en) | 2012-02-29 | 2016-08-30 | Fluidigm Corporation | Methods, systems and devices for multiple single-cell capturing and processing using microfluidics |
US9731293B2 (en) * | 2012-10-03 | 2017-08-15 | The United States Of America, As Represented By The Secretary Of The Navy | Paired laser and electrokinetic separation, manipulation, and analysis device |
US9757726B2 (en) | 2013-03-14 | 2017-09-12 | Inguran, Llc | System for high throughput sperm sorting |
US10371622B2 (en) | 2013-03-14 | 2019-08-06 | Inguran, Llc | Device for high throughput sperm sorting |
US10662408B2 (en) | 2013-03-14 | 2020-05-26 | Inguran, Llc | Methods for high throughput sperm sorting |
US10180388B2 (en) | 2015-02-19 | 2019-01-15 | 1087 Systems, Inc. | Scanning infrared measurement system |
CN105396632B (en) * | 2015-12-14 | 2017-05-10 | 苏州汶颢芯片科技有限公司 | Liquid drop collection device based on micro-fluidic chip |
EP3512633A1 (en) * | 2016-10-12 | 2019-07-24 | MyCartis N.V. | Prefilled cartridge |
US20210260587A1 (en) * | 2018-07-11 | 2021-08-26 | The University Of Hong Kong | Automatic microfluidic system for continuous and quantitive collection of droplets |
EP4018175A4 (en) * | 2019-08-22 | 2022-10-05 | Iannotti, Michael | High throughput analysis and sorting, and sampling interface and assembly for high throughput analysis and sorting |
AU2020361681A1 (en) | 2019-10-10 | 2022-05-05 | 1859, Inc. | Methods and systems for microfluidic screening |
LU101790B1 (en) | 2020-05-11 | 2021-11-12 | Diatron MI PLC | Disposable injection moldable flow cell for use in flow cytometry |
Citations (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4793705A (en) * | 1987-10-07 | 1988-12-27 | The United States Of America As Represented By The United States Department Of Energy | Single molecule tracking |
US5316906A (en) | 1991-08-23 | 1994-05-31 | Molecular Probes, Inc. | Enzymatic analysis using substrates that yield fluorescent precipitates |
WO1995002189A1 (en) | 1993-07-07 | 1995-01-19 | Abaxis, Inc. | System and method for incorporating analytical instruments within personal computers |
EP0745682A1 (en) | 1995-06-02 | 1996-12-04 | Bayer Ag | Sorting apparatus for biological cells and viruses |
US5608519A (en) * | 1995-03-20 | 1997-03-04 | Gourley; Paul L. | Laser apparatus and method for microscopic and spectroscopic analysis and processing of biological cells |
WO1998000231A1 (en) | 1996-06-28 | 1998-01-08 | Caliper Technologies Corporation | High-throughput screening assay systems in microscale fluidic devices |
WO1998010267A1 (en) | 1996-09-04 | 1998-03-12 | Technical University Of Denmark | A micro flow system for particle separation and analysis |
WO1998045481A1 (en) | 1997-04-04 | 1998-10-15 | Caliper Technologies Corporation | Closed-loop biochemical analyzers |
US5858187A (en) * | 1996-09-26 | 1999-01-12 | Lockheed Martin Energy Systems, Inc. | Apparatus and method for performing electrodynamic focusing on a microchip |
US5942443A (en) | 1996-06-28 | 1999-08-24 | Caliper Technologies Corporation | High throughput screening assay systems in microscale fluidic devices |
US5972710A (en) * | 1996-03-29 | 1999-10-26 | University Of Washington | Microfabricated diffusion-based chemical sensor |
US6049380A (en) * | 1997-11-12 | 2000-04-11 | Regents Of The University Of California | Single molecule identification using selected fluorescence characteristics |
US6067157A (en) * | 1998-10-09 | 2000-05-23 | University Of Washington | Dual large angle light scattering detection |
WO2000043766A1 (en) | 1999-01-21 | 2000-07-27 | Caliper Technologies Corp. | Method and apparatus for continuous liquid flow in microscale channels using pressure injection, wicking, and electrokinetic injection |
WO2000050172A1 (en) | 1999-02-23 | 2000-08-31 | Caliper Technologies Corp. | Manipulation of microparticles in microfluidic systems |
US9806723B2 (en) | 2014-04-04 | 2017-10-31 | International Business Machines Corporation | Digital phase locked loop for low jitter applications |
Family Cites Families (49)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4390403A (en) | 1981-07-24 | 1983-06-28 | Batchelder J Samuel | Method and apparatus for dielectrophoretic manipulation of chemical species |
US4844610A (en) * | 1988-04-29 | 1989-07-04 | Becton, Dickinson And Company | Backflow isolator and capture system |
US4908112A (en) | 1988-06-16 | 1990-03-13 | E. I. Du Pont De Nemours & Co. | Silicon semiconductor wafer for analyzing micronic biological samples |
US5750015A (en) | 1990-02-28 | 1998-05-12 | Soane Biosciences | Method and device for moving molecules by the application of a plurality of electrical fields |
US5126022A (en) | 1990-02-28 | 1992-06-30 | Soane Tecnologies, Inc. | Method and device for moving molecules by the application of a plurality of electrical fields |
US5587128A (en) | 1992-05-01 | 1996-12-24 | The Trustees Of The University Of Pennsylvania | Mesoscale polynucleotide amplification devices |
US5637469A (en) | 1992-05-01 | 1997-06-10 | Trustees Of The University Of Pennsylvania | Methods and apparatus for the detection of an analyte utilizing mesoscale flow systems |
US5304487A (en) | 1992-05-01 | 1994-04-19 | Trustees Of The University Of Pennsylvania | Fluid handling in mesoscale analytical devices |
US5498392A (en) | 1992-05-01 | 1996-03-12 | Trustees Of The University Of Pennsylvania | Mesoscale polynucleotide amplification device and method |
NO932088L (en) * | 1993-06-08 | 1995-01-05 | Oddbjoern Gjelsnes | Device for use in liquid flow cytometry |
US6001229A (en) | 1994-08-01 | 1999-12-14 | Lockheed Martin Energy Systems, Inc. | Apparatus and method for performing microfluidic manipulations for chemical analysis |
US5571410A (en) | 1994-10-19 | 1996-11-05 | Hewlett Packard Company | Fully integrated miniaturized planar liquid sample handling and analysis device |
US5603351A (en) | 1995-06-07 | 1997-02-18 | David Sarnoff Research Center, Inc. | Method and system for inhibiting cross-contamination in fluids of combinatorial chemistry device |
US5585069A (en) | 1994-11-10 | 1996-12-17 | David Sarnoff Research Center, Inc. | Partitioned microelectronic and fluidic device array for clinical diagnostics and chemical synthesis |
US5856174A (en) | 1995-06-29 | 1999-01-05 | Affymetrix, Inc. | Integrated nucleic acid diagnostic device |
US5972622A (en) * | 1996-02-08 | 1999-10-26 | Desjardins; Louise | Method of detecting apoptosis using an anti-human GP46 monoclonal anti-body |
US5707808A (en) * | 1996-04-15 | 1998-01-13 | The Regents Of The University Of California | Optical selection and collection of DNA fragments |
US5885470A (en) | 1997-04-14 | 1999-03-23 | Caliper Technologies Corporation | Controlled fluid transport in microfabricated polymeric substrates |
US6399023B1 (en) | 1996-04-16 | 2002-06-04 | Caliper Technologies Corp. | Analytical system and method |
US5779868A (en) | 1996-06-28 | 1998-07-14 | Caliper Technologies Corporation | Electropipettor and compensation means for electrophoretic bias |
BR9710052A (en) | 1996-06-28 | 2000-01-11 | Caliper Techn Corp | Microfluid system with compensation for electrophoretic polarization, electropipettor, processes for introducing materials from a series of sources into a microfluidic system, for controllably distributing a fluid stream and for transporting fluid samples, sampling system, use of a substrate , use of a microfluidic system, and substrate. |
US5800690A (en) | 1996-07-03 | 1998-09-01 | Caliper Technologies Corporation | Variable control of electroosmotic and/or electrophoretic forces within a fluid-containing structure via electrical forces |
US5699157A (en) | 1996-07-16 | 1997-12-16 | Caliper Technologies Corp. | Fourier detection of species migrating in a microchannel |
US6120666A (en) * | 1996-09-26 | 2000-09-19 | Ut-Battelle, Llc | Microfabricated device and method for multiplexed electrokinetic focusing of fluid streams and a transport cytometry method using same |
US6447727B1 (en) | 1996-11-19 | 2002-09-10 | Caliper Technologies Corp. | Microfluidic systems |
US6159739A (en) * | 1997-03-26 | 2000-12-12 | University Of Washington | Device and method for 3-dimensional alignment of particles in microfabricated flow channels |
US5964995A (en) | 1997-04-04 | 1999-10-12 | Caliper Technologies Corp. | Methods and systems for enhanced fluid transport |
KR100351531B1 (en) | 1997-04-25 | 2002-09-11 | 캘리퍼 테크놀로지스 코포레이션 | Microfludic devices incorporating improved channel geometries |
US5976336A (en) | 1997-04-25 | 1999-11-02 | Caliper Technologies Corp. | Microfluidic devices incorporating improved channel geometries |
US6090251A (en) | 1997-06-06 | 2000-07-18 | Caliper Technologies, Inc. | Microfabricated structures for facilitating fluid introduction into microfluidic devices |
US5869004A (en) | 1997-06-09 | 1999-02-09 | Caliper Technologies Corp. | Methods and apparatus for in situ concentration and/or dilution of materials in microfluidic systems |
CA2291854A1 (en) | 1997-06-09 | 1998-12-17 | Steven A. Sundberg | Apparatus and methods for correcting for variable velocity in microfluidic systems |
US5882465A (en) | 1997-06-18 | 1999-03-16 | Caliper Technologies Corp. | Method of manufacturing microfluidic devices |
US5959291A (en) | 1997-06-27 | 1999-09-28 | Caliper Technologies Corporation | Method and apparatus for measuring low power signals |
US6001231A (en) * | 1997-07-15 | 1999-12-14 | Caliper Technologies Corp. | Methods and systems for monitoring and controlling fluid flow rates in microfluidic systems |
US5876675A (en) | 1997-08-05 | 1999-03-02 | Caliper Technologies Corp. | Microfluidic devices and systems |
US5989402A (en) | 1997-08-29 | 1999-11-23 | Caliper Technologies Corp. | Controller/detector interfaces for microfluidic systems |
EP1009995A4 (en) | 1997-09-02 | 2007-05-02 | Caliper Life Sciences Inc | Microfluidic system with electrofluidic and electrothermal controls |
US5965410A (en) | 1997-09-02 | 1999-10-12 | Caliper Technologies Corp. | Electrical current for controlling fluid parameters in microchannels |
US6012902A (en) | 1997-09-25 | 2000-01-11 | Caliper Technologies Corp. | Micropump |
US5842787A (en) | 1997-10-09 | 1998-12-01 | Caliper Technologies Corporation | Microfluidic systems incorporating varied channel dimensions |
US5958694A (en) | 1997-10-16 | 1999-09-28 | Caliper Technologies Corp. | Apparatus and methods for sequencing nucleic acids in microfluidic systems |
US6074725A (en) | 1997-12-10 | 2000-06-13 | Caliper Technologies Corp. | Fabrication of microfluidic circuits by printing techniques |
US5948227A (en) | 1997-12-17 | 1999-09-07 | Caliper Technologies Corp. | Methods and systems for performing electrophoretic molecular separations |
US6123798A (en) | 1998-05-06 | 2000-09-26 | Caliper Technologies Corp. | Methods of fabricating polymeric structures incorporating microscale fluidic elements |
AU5479599A (en) | 1998-08-11 | 2000-03-06 | Caliper Technologies Corporation | Methods and systems for sequencing dna by distinguishing the decay times of fluorescent probes |
DE19847952C2 (en) * | 1998-09-01 | 2000-10-05 | Inst Physikalische Hochtech Ev | Fluid flow switch |
US6150119A (en) * | 1999-01-19 | 2000-11-21 | Caliper Technologies Corp. | Optimized high-throughput analytical system |
US6607157B1 (en) | 1999-07-14 | 2003-08-19 | Keltech Engineering, Inc. | Air bearing system with an air cylinder web dancer system or idler rolls |
-
2000
- 2000-05-11 AU AU50158/00A patent/AU770678B2/en not_active Ceased
- 2000-05-11 EP EP00932435.1A patent/EP1179087B1/en not_active Expired - Lifetime
- 2000-05-11 WO PCT/US2000/013294 patent/WO2000070080A1/en active IP Right Grant
- 2000-05-11 CA CA002373347A patent/CA2373347A1/en not_active Abandoned
- 2000-05-11 US US09/569,747 patent/US6506609B1/en not_active Expired - Lifetime
Patent Citations (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4793705A (en) * | 1987-10-07 | 1988-12-27 | The United States Of America As Represented By The United States Department Of Energy | Single molecule tracking |
US5316906A (en) | 1991-08-23 | 1994-05-31 | Molecular Probes, Inc. | Enzymatic analysis using substrates that yield fluorescent precipitates |
US5443986A (en) | 1991-08-23 | 1995-08-22 | Molecular Probes, Inc. | Enzymatic analysis using substrates that yield fluorescent precipitates |
WO1995002189A1 (en) | 1993-07-07 | 1995-01-19 | Abaxis, Inc. | System and method for incorporating analytical instruments within personal computers |
US5608519A (en) * | 1995-03-20 | 1997-03-04 | Gourley; Paul L. | Laser apparatus and method for microscopic and spectroscopic analysis and processing of biological cells |
EP0745682A1 (en) | 1995-06-02 | 1996-12-04 | Bayer Ag | Sorting apparatus for biological cells and viruses |
US5972710A (en) * | 1996-03-29 | 1999-10-26 | University Of Washington | Microfabricated diffusion-based chemical sensor |
WO1998000231A1 (en) | 1996-06-28 | 1998-01-08 | Caliper Technologies Corporation | High-throughput screening assay systems in microscale fluidic devices |
US5942443A (en) | 1996-06-28 | 1999-08-24 | Caliper Technologies Corporation | High throughput screening assay systems in microscale fluidic devices |
WO1998010267A1 (en) | 1996-09-04 | 1998-03-12 | Technical University Of Denmark | A micro flow system for particle separation and analysis |
US5858187A (en) * | 1996-09-26 | 1999-01-12 | Lockheed Martin Energy Systems, Inc. | Apparatus and method for performing electrodynamic focusing on a microchip |
WO1998045481A1 (en) | 1997-04-04 | 1998-10-15 | Caliper Technologies Corporation | Closed-loop biochemical analyzers |
US6049380A (en) * | 1997-11-12 | 2000-04-11 | Regents Of The University Of California | Single molecule identification using selected fluorescence characteristics |
US6067157A (en) * | 1998-10-09 | 2000-05-23 | University Of Washington | Dual large angle light scattering detection |
WO2000043766A1 (en) | 1999-01-21 | 2000-07-27 | Caliper Technologies Corp. | Method and apparatus for continuous liquid flow in microscale channels using pressure injection, wicking, and electrokinetic injection |
WO2000050172A1 (en) | 1999-02-23 | 2000-08-31 | Caliper Technologies Corp. | Manipulation of microparticles in microfluidic systems |
WO2000050642A1 (en) | 1999-02-23 | 2000-08-31 | Caliper Technologies Corp. | Sequencing by incorporation |
US9806723B2 (en) | 2014-04-04 | 2017-10-31 | International Business Machines Corporation | Digital phase locked loop for low jitter applications |
Non-Patent Citations (13)
Title |
---|
ARENDS ET AL., AM. J. PATHOL., vol. 136, 1990, pages 593 |
BLANKENSTEIN, G. ET AL.: "Anal. Method. Instrum.", 1996, JOHN WILEY & SONS, article "Flow Switch for Analyte Injection and Cell/Particle Sorting", pages: 82 - 84 |
CHOU, H.P. ET AL.: "A Microfabricated Device for Sizing and Sorting DNA Molecules", PROC. NAT']. ACAD. SCI., vol. 96, 1999, pages 11 - 13, XP002217376, DOI: doi:10.1073/pnas.96.1.11 |
CLARKE, ANAT. EMBRV)., vol. 181, 1990, pages 195 |
FU, A.Y.: "A Microfabricated Fluorescence-Activated Cell Sorter", NAT. BIOTECHNOL., vol. 17, 1999, pages 1109 - 1111, XP001152150, DOI: doi:10.1038/15095 |
ISHIGAMI ET AL., J. IMMUNOL., vol. 148, 1992, pages 360 |
KERR ET AL., BR. J. CANCER, vol. 26, pages 239 |
KESSLER B.O.: "Hydrodynamic focusing of motile algal cells", NATURE, vol. 313, 17 January 1985 (1985-01-17), pages 218 - 220, XP002930420 * |
KNIGHT ET AL.: "Hydrodynamic focusing on a silicon chip: Mixing nanoliters in microseconds", PHYSICAL REVIEW LETTERS, vol. 80, no. 17, 27 April 1998 (1998-04-27), pages 3863 - 3866, XP002930419 * |
KONONENKO ET AL.: "Non-equilibrium integral Doppler anemometric analysis of particle mixtures in a channel flow using an intrisic hydrodynamic focusing force biased by another force", JOURNAL OF CHROMATOGRAPHY, vol. 553, 1991, pages 517 - 530, XP002930418 * |
MARTIN ET AL., J. CELL BIOL., vol. 106, 1988, pages 829 |
UNGER, M. ET AL.: "Single Molecule Fluorescence Observed with Mercury Lamp Illumination", BIOTECHNIQUES, vol. 27, 1999, pages 1008 - 1013 |
WATSON: "The early fluidic and optical physics of cytometry", CYTOMETRY, vol. 38, 1999, pages 2 - 14, XP002930417 * |
Cited By (175)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9422523B2 (en) | 1997-12-31 | 2016-08-23 | Xy, Llc | System and method for sorting cells |
US9365822B2 (en) | 1997-12-31 | 2016-06-14 | Xy, Llc | System and method for sorting cells |
US6576194B1 (en) * | 1998-05-18 | 2003-06-10 | University Of Washington | Sheath flow assembly |
US8518705B2 (en) | 1999-08-13 | 2013-08-27 | Pathogenetix, Inc. | Methods and apparatuses for stretching polymers |
US9376718B2 (en) | 2000-11-16 | 2016-06-28 | Caliper Life Sciences, Inc. | Method and apparatus for generating thermal melting curves in a microfluidic device |
US8900811B2 (en) | 2000-11-16 | 2014-12-02 | Caliper Life Sciences, Inc. | Method and apparatus for generating thermal melting curves in a microfluidic device |
US10871460B2 (en) | 2000-11-16 | 2020-12-22 | Canon U.S.A., Inc. | Method and apparatus for generating thermal melting curves in a microfluidic device |
US9983155B2 (en) | 2000-11-16 | 2018-05-29 | Canon U.S. Life Sciences, Inc. | Method and apparatus for generating thermal melting curves in a microfluidic device |
US11162910B2 (en) | 2000-11-16 | 2021-11-02 | Caliper Life Sciences, Inc. | Method and apparatus for generating thermal melting curves in a microfluidic device |
US9879221B2 (en) | 2000-11-29 | 2018-01-30 | Xy, Llc | Method of in-vitro fertilization with spermatozoa separated into X-chromosome and Y-chromosome bearing populations |
US8216852B2 (en) | 2001-07-27 | 2012-07-10 | Caliper Life Sciences, Inc. | Channel cross-section geometry to manipulate dispersion rates |
US7247274B1 (en) | 2001-11-13 | 2007-07-24 | Caliper Technologies Corp. | Prevention of precipitate blockage in microfluidic channels |
US10710120B2 (en) | 2002-04-17 | 2020-07-14 | Cytonome/St, Llc | Method and apparatus for sorting particles |
US11027278B2 (en) | 2002-04-17 | 2021-06-08 | Cytonome/St, Llc | Methods for controlling fluid flow in a microfluidic system |
US9943847B2 (en) | 2002-04-17 | 2018-04-17 | Cytonome/St, Llc | Microfluidic system including a bubble valve for regulating fluid flow through a microchannel |
US7584857B2 (en) | 2002-04-17 | 2009-09-08 | Cytonome/St, Llc | Method and apparatus for sorting particles |
AU2003228630B2 (en) * | 2002-04-17 | 2009-10-22 | Cytonome/St, Llc | Method and apparatus for sorting particles |
US10029283B2 (en) | 2002-04-17 | 2018-07-24 | Cytonome/St, Llc | Method and apparatus for sorting particles |
US9550215B2 (en) | 2002-04-17 | 2017-01-24 | Cytonome/St, Llc | Method and apparatus for sorting particles |
US7569788B2 (en) | 2002-04-17 | 2009-08-04 | Cytonome/St, Llc | Method and apparatus for sorting particles |
US9011797B2 (en) | 2002-04-17 | 2015-04-21 | Cytonome/St, Llc | Microfluidic system including a bubble valve for regulating fluid flow through a microchannel |
US10029263B2 (en) | 2002-04-17 | 2018-07-24 | Cytonome/St, Llc | Method and apparatus for sorting particles |
US10427159B2 (en) | 2002-04-17 | 2019-10-01 | Cytonome/St, Llc | Microfluidic device |
US8623295B2 (en) | 2002-04-17 | 2014-01-07 | Cytonome/St, Llc | Microfluidic system including a bubble valve for regulating fluid flow through a microchannel |
US7963399B2 (en) | 2002-04-17 | 2011-06-21 | Cytonome/St, Llc | Method and apparatus for sorting particles |
US9339850B2 (en) | 2002-04-17 | 2016-05-17 | Cytonome/St, Llc | Method and apparatus for sorting particles |
US8986628B2 (en) | 2002-06-28 | 2015-03-24 | President And Fellows Of Harvard College | Method and apparatus for fluid dispersion |
US7708949B2 (en) | 2002-06-28 | 2010-05-04 | President And Fellows Of Harvard College | Method and apparatus for fluid dispersion |
WO2004002627A2 (en) * | 2002-06-28 | 2004-01-08 | President And Fellows Of Harvard College | Method and apparatus for fluid dispersion |
US8337778B2 (en) | 2002-06-28 | 2012-12-25 | President And Fellows Of Harvard College | Method and apparatus for fluid dispersion |
WO2004002627A3 (en) * | 2002-06-28 | 2004-04-01 | Harvard College | Method and apparatus for fluid dispersion |
US11415936B2 (en) | 2002-07-31 | 2022-08-16 | Abs Global, Inc. | Multiple laminar flow-based particle and cellular separation with laser steering |
US11243494B2 (en) | 2002-07-31 | 2022-02-08 | Abs Global, Inc. | Multiple laminar flow-based particle and cellular separation with laser steering |
US11422504B2 (en) | 2002-07-31 | 2022-08-23 | Abs Global, Inc. | Multiple laminar flow-based particle and cellular separation with laser steering |
NL1024013C2 (en) * | 2002-08-30 | 2005-07-19 | Intel Corp | Cascading (cascade) hydrodynamic aiming in microfluidic channels. |
GB2392397A (en) * | 2002-08-30 | 2004-03-03 | Intel Corp | Fluid focussing in a microfluidic device |
GB2392397B (en) * | 2002-08-30 | 2005-01-19 | Intel Corp | Cascaded hydrodynamic focusing in microfluidic channels |
US11230695B2 (en) | 2002-09-13 | 2022-01-25 | Xy, Llc | Sperm cell processing and preservation systems |
US11261424B2 (en) | 2002-09-13 | 2022-03-01 | Xy, Llc | Sperm cell processing systems |
US11187702B2 (en) | 2003-03-14 | 2021-11-30 | Bio-Rad Laboratories, Inc. | Enzyme quantification |
US9040304B2 (en) | 2003-03-28 | 2015-05-26 | Inguran, Llc | Multi-channel system and methods for sorting particles |
US9377390B2 (en) | 2003-03-28 | 2016-06-28 | Inguran, Llc | Apparatus, methods and processes for sorting particles and for providing sex-sorted animal sperm |
US11718826B2 (en) | 2003-03-28 | 2023-08-08 | Inguran, Llc | System and method for sorting particles |
US11104880B2 (en) | 2003-03-28 | 2021-08-31 | Inguran, Llc | Photo-damage system for sorting particles |
US10100278B2 (en) | 2003-03-28 | 2018-10-16 | Inguran, Llc | Multi-channel system and methods for sorting particles |
US9857303B2 (en) | 2003-03-31 | 2018-01-02 | Medical Research Council | Selection by compartmentalised screening |
US9448172B2 (en) | 2003-03-31 | 2016-09-20 | Medical Research Council | Selection by compartmentalised screening |
US10052605B2 (en) | 2003-03-31 | 2018-08-21 | Medical Research Council | Method of synthesis and testing of combinatorial libraries using microcapsules |
EP3616781A1 (en) * | 2003-04-10 | 2020-03-04 | President and Fellows of Harvard College | Formation and control of fluidic species |
US20220097067A1 (en) * | 2003-04-10 | 2022-03-31 | President And Fellows Of Harvard College | Formation and control of fluidic species |
US20150283546A1 (en) | 2003-04-10 | 2015-10-08 | President And Fellows Of Harvard College | Formation and control of fluidic species |
US9038919B2 (en) | 2003-04-10 | 2015-05-26 | President And Fellows Of Harvard College | Formation and control of fluidic species |
US10293341B2 (en) | 2003-04-10 | 2019-05-21 | President And Fellows Of Harvard College | Formation and control of fluidic species |
US11141731B2 (en) | 2003-04-10 | 2021-10-12 | President And Fellows Of Harvard College | Formation and control of fluidic species |
DE10318864B3 (en) * | 2003-04-25 | 2004-09-23 | Siemens Ag | Micro-fluidic valve, for controlled introduction of fluid into channel during capillary electrophoresis, combines electrical potential gradient with curvature inducing Coanda effect |
US10625256B2 (en) | 2003-08-27 | 2020-04-21 | President And Fellows Of Harvard College | Electronic control of fluidic species |
US9878325B2 (en) | 2003-08-27 | 2018-01-30 | President And Fellows Of Harvard College | Electronic control of fluidic species |
US11383234B2 (en) | 2003-08-27 | 2022-07-12 | President And Fellows Of Harvard College | Electronic control of fluidic species |
US9789482B2 (en) | 2003-08-27 | 2017-10-17 | President And Fellows Of Harvard College | Methods of introducing a fluid into droplets |
AU2011205167B2 (en) * | 2003-10-30 | 2013-01-24 | Cytonome/St, Llc | Multilayer hydrodynamic sheath flow structure |
US8529161B2 (en) | 2003-10-30 | 2013-09-10 | Cytonome/St, Llc | Multilayer hydrodynamic sheath flow structure |
US11634286B2 (en) | 2003-10-30 | 2023-04-25 | Cytonome/St, Llc | Multilayer hydrodynamic sheath flow structure |
AU2011205167B9 (en) * | 2003-10-30 | 2013-02-07 | Cytonome/St, Llc | Multilayer hydrodynamic sheath flow structure |
JP2007514522A (en) * | 2003-10-30 | 2007-06-07 | サイトノーム インコーポレーテッド | Hydrodynamic multilayer sheath flow structure |
EP1682438A2 (en) * | 2003-10-30 | 2006-07-26 | Cytonome, Inc. | Multilayer hydrodynamic sheath flow structure |
US10689210B2 (en) | 2003-10-30 | 2020-06-23 | Cytonome/St, Llc | Multilayer hydrodynamic sheath flow structure |
EP1682438A4 (en) * | 2003-10-30 | 2009-08-05 | Cytonome Inc | Multilayer hydrodynamic sheath flow structure |
US9802767B2 (en) | 2003-10-30 | 2017-10-31 | Cytonome/St, Llc | Multilayer hydrodynamic sheath flow structure |
US10543992B2 (en) | 2003-10-30 | 2020-01-28 | Cytonome/St, Llc | Multilayer hydrodynamic sheath flow structure |
US11873173B2 (en) | 2003-10-30 | 2024-01-16 | Cytonome/St, Llc | Multilayer hydrodynamic sheath flow structure |
WO2005042137A2 (en) | 2003-10-30 | 2005-05-12 | Cytonome, Inc. | Multilayer hydrodynamic sheath flow structure |
US9839890B2 (en) | 2004-03-31 | 2017-12-12 | National Science Foundation | Compartmentalised combinatorial chemistry by microfluidic control |
US11821109B2 (en) | 2004-03-31 | 2023-11-21 | President And Fellows Of Harvard College | Compartmentalised combinatorial chemistry by microfluidic control |
US9925504B2 (en) | 2004-03-31 | 2018-03-27 | President And Fellows Of Harvard College | Compartmentalised combinatorial chemistry by microfluidic control |
US10732649B2 (en) | 2004-07-02 | 2020-08-04 | The University Of Chicago | Microfluidic system |
US8871444B2 (en) | 2004-10-08 | 2014-10-28 | Medical Research Council | In vitro evolution in microfluidic systems |
US9186643B2 (en) | 2004-10-08 | 2015-11-17 | Medical Research Council | In vitro evolution in microfluidic systems |
US9029083B2 (en) | 2004-10-08 | 2015-05-12 | Medical Research Council | Vitro evolution in microfluidic systems |
US11786872B2 (en) | 2004-10-08 | 2023-10-17 | United Kingdom Research And Innovation | Vitro evolution in microfluidic systems |
US9498759B2 (en) | 2004-10-12 | 2016-11-22 | President And Fellows Of Harvard College | Compartmentalized screening by microfluidic control |
US10994273B2 (en) | 2004-12-03 | 2021-05-04 | Cytonome/St, Llc | Actuation of parallel microfluidic arrays |
US10316873B2 (en) | 2005-03-04 | 2019-06-11 | President And Fellows Of Harvard College | Method and apparatus for forming multiple emulsions |
US9039273B2 (en) | 2005-03-04 | 2015-05-26 | President And Fellows Of Harvard College | Method and apparatus for forming multiple emulsions |
WO2007042126A1 (en) * | 2005-10-07 | 2007-04-19 | HAHN-SCHICKARD-GESELLSCHAFT FÜR ANGEWANDTE FORSCHUNG e-V. | Apparatus and method for producing a mixture of two phases that are insoluble in each other |
US9534216B2 (en) | 2006-01-11 | 2017-01-03 | Raindance Technologies, Inc. | Microfluidic devices and methods of use in the formation and control of nanoreactors |
US9410151B2 (en) | 2006-01-11 | 2016-08-09 | Raindance Technologies, Inc. | Microfluidic devices and methods of use in the formation and control of nanoreactors |
US9328344B2 (en) | 2006-01-11 | 2016-05-03 | Raindance Technologies, Inc. | Microfluidic devices and methods of use in the formation and control of nanoreactors |
US11351510B2 (en) | 2006-05-11 | 2022-06-07 | Bio-Rad Laboratories, Inc. | Microfluidic devices |
US9562837B2 (en) | 2006-05-11 | 2017-02-07 | Raindance Technologies, Inc. | Systems for handling microfludic droplets |
US9273308B2 (en) | 2006-05-11 | 2016-03-01 | Raindance Technologies, Inc. | Selection of compartmentalized screening method |
US9498761B2 (en) | 2006-08-07 | 2016-11-22 | Raindance Technologies, Inc. | Fluorocarbon emulsion stabilizing surfactants |
US9012390B2 (en) | 2006-08-07 | 2015-04-21 | Raindance Technologies, Inc. | Fluorocarbon emulsion stabilizing surfactants |
US9360476B2 (en) | 2006-12-19 | 2016-06-07 | Fio Corporation | Microfluidic system and method to test for target molecules in a biological sample |
CN101680893B (en) * | 2006-12-19 | 2014-11-19 | Fio公司 | Microfluidic system and method to test for target molecules in a biological sample |
EP2115471A4 (en) * | 2006-12-19 | 2010-03-03 | Fio Corp | Microfluidic system and method to test for target molecules in a biological sample |
EP2115471A1 (en) * | 2006-12-19 | 2009-11-11 | Fio Corporation | Microfluidic system and method to test for target molecules in a biological sample |
US8999636B2 (en) | 2007-01-08 | 2015-04-07 | Toxic Report Llc | Reaction chamber |
US9017623B2 (en) | 2007-02-06 | 2015-04-28 | Raindance Technologies, Inc. | Manipulation of fluids and reactions in microfluidic systems |
US10603662B2 (en) | 2007-02-06 | 2020-03-31 | Brandeis University | Manipulation of fluids and reactions in microfluidic systems |
US9440232B2 (en) | 2007-02-06 | 2016-09-13 | Raindance Technologies, Inc. | Manipulation of fluids and reactions in microfluidic systems |
US11819849B2 (en) | 2007-02-06 | 2023-11-21 | Brandeis University | Manipulation of fluids and reactions in microfluidic systems |
US7776927B2 (en) | 2007-03-28 | 2010-08-17 | President And Fellows Of Harvard College | Emulsions and techniques for formation |
US11618024B2 (en) | 2007-04-19 | 2023-04-04 | President And Fellows Of Harvard College | Manipulation of fluids, fluid components and reactions in microfluidic systems |
US10675626B2 (en) | 2007-04-19 | 2020-06-09 | President And Fellows Of Harvard College | Manipulation of fluids, fluid components and reactions in microfluidic systems |
US10960397B2 (en) | 2007-04-19 | 2021-03-30 | President And Fellows Of Harvard College | Manipulation of fluids, fluid components and reactions in microfluidic systems |
US9068699B2 (en) | 2007-04-19 | 2015-06-30 | Brandeis University | Manipulation of fluids, fluid components and reactions in microfluidic systems |
US10357772B2 (en) | 2007-04-19 | 2019-07-23 | President And Fellows Of Harvard College | Manipulation of fluids, fluid components and reactions in microfluidic systems |
US11224876B2 (en) | 2007-04-19 | 2022-01-18 | Brandeis University | Manipulation of fluids, fluid components and reactions in microfluidic systems |
EP3677336A1 (en) | 2007-09-05 | 2020-07-08 | Caliper Life Sciences Inc. | Microfluidic method and system for enzyme inhibition activity screening |
US9695482B2 (en) | 2007-10-12 | 2017-07-04 | Fio Coporation | Flow focusing method and system for forming concentrated volumes of microbeads, and microbeads formed further thereto |
WO2009061392A1 (en) * | 2007-11-05 | 2009-05-14 | President And Fellows Of Harvard College | Forming gel structures using microfluidic channels |
US9792809B2 (en) | 2008-06-25 | 2017-10-17 | Fio Corporation | Bio-threat alert system |
US10533998B2 (en) | 2008-07-18 | 2020-01-14 | Bio-Rad Laboratories, Inc. | Enzyme quantification |
US11511242B2 (en) | 2008-07-18 | 2022-11-29 | Bio-Rad Laboratories, Inc. | Droplet libraries |
US12038438B2 (en) | 2008-07-18 | 2024-07-16 | Bio-Rad Laboratories, Inc. | Enzyme quantification |
US11534727B2 (en) | 2008-07-18 | 2022-12-27 | Bio-Rad Laboratories, Inc. | Droplet libraries |
US11596908B2 (en) | 2008-07-18 | 2023-03-07 | Bio-Rad Laboratories, Inc. | Droplet libraries |
US9459200B2 (en) | 2008-08-29 | 2016-10-04 | Fio Corporation | Single-use handheld diagnostic test device, and an associated system and method for testing biological and environmental test samples |
US9945837B2 (en) | 2008-08-29 | 2018-04-17 | Fio Corporation | Single-use handheld diagnostic test device, and an associated system and method for testing biological and environmental test samples |
WO2010034908A1 (en) * | 2008-09-25 | 2010-04-01 | Etat Français représenté par le Délégué Général pour L'Armement | Device for the selective preconcentration/detection of charged analytes contained in an electrolyte, and related method |
FR2936316A1 (en) * | 2008-09-25 | 2010-03-26 | Etat Francais Dga | DEVICE FOR SELECTIVE PRECONCENTRATION / DETECTION OF CHARGED ANALYTES CONTAINED IN AN ELECTROLYTE AND ASSOCIATED METHOD. |
US8361716B2 (en) | 2008-10-03 | 2013-01-29 | Pathogenetix, Inc. | Focusing chamber |
US11385219B2 (en) | 2009-01-13 | 2022-07-12 | Fio Corporation | Handheld diagnostic test device and method for use with an electronic device and a test cartridge in a rapid diagnostic test |
US9805165B2 (en) | 2009-01-13 | 2017-10-31 | Fio Corporation | Handheld diagnostic test device and method for use with an electronic device and a test cartridge in a rapid diagnostic test |
US11268887B2 (en) | 2009-03-23 | 2022-03-08 | Bio-Rad Laboratories, Inc. | Manipulation of microfluidic droplets |
US10874997B2 (en) | 2009-09-02 | 2020-12-29 | President And Fellows Of Harvard College | Multiple emulsions created using jetting and other techniques |
US10520500B2 (en) | 2009-10-09 | 2019-12-31 | Abdeslam El Harrak | Labelled silica-based nanomaterial with enhanced properties and uses thereof |
US10837883B2 (en) | 2009-12-23 | 2020-11-17 | Bio-Rad Laboratories, Inc. | Microfluidic systems and methods for reducing the exchange of molecules between droplets |
US9399797B2 (en) | 2010-02-12 | 2016-07-26 | Raindance Technologies, Inc. | Digital analyte analysis |
US9366632B2 (en) | 2010-02-12 | 2016-06-14 | Raindance Technologies, Inc. | Digital analyte analysis |
US10351905B2 (en) | 2010-02-12 | 2019-07-16 | Bio-Rad Laboratories, Inc. | Digital analyte analysis |
US11390917B2 (en) | 2010-02-12 | 2022-07-19 | Bio-Rad Laboratories, Inc. | Digital analyte analysis |
US11254968B2 (en) | 2010-02-12 | 2022-02-22 | Bio-Rad Laboratories, Inc. | Digital analyte analysis |
US10808279B2 (en) | 2010-02-12 | 2020-10-20 | Bio-Rad Laboratories, Inc. | Digital analyte analysis |
US9074242B2 (en) | 2010-02-12 | 2015-07-07 | Raindance Technologies, Inc. | Digital analyte analysis |
US9228229B2 (en) | 2010-02-12 | 2016-01-05 | Raindance Technologies, Inc. | Digital analyte analysis |
US9562897B2 (en) | 2010-09-30 | 2017-02-07 | Raindance Technologies, Inc. | Sandwich assays in droplets |
US11635427B2 (en) | 2010-09-30 | 2023-04-25 | Bio-Rad Laboratories, Inc. | Sandwich assays in droplets |
US11193879B2 (en) | 2010-11-16 | 2021-12-07 | 1087 Systems, Inc. | Use of vibrational spectroscopy for microfluidic liquid measurement |
US11965816B2 (en) | 2010-11-16 | 2024-04-23 | 1087 Systems, Inc. | Use of vibrational spectroscopy for microfluidic liquid measurement |
US11077415B2 (en) | 2011-02-11 | 2021-08-03 | Bio-Rad Laboratories, Inc. | Methods for forming mixed droplets |
US9364803B2 (en) | 2011-02-11 | 2016-06-14 | Raindance Technologies, Inc. | Methods for forming mixed droplets |
US11965877B2 (en) | 2011-02-18 | 2024-04-23 | Bio-Rad Laboratories, Inc. | Compositions and methods for molecular labeling |
US9150852B2 (en) | 2011-02-18 | 2015-10-06 | Raindance Technologies, Inc. | Compositions and methods for molecular labeling |
US11168353B2 (en) | 2011-02-18 | 2021-11-09 | Bio-Rad Laboratories, Inc. | Compositions and methods for molecular labeling |
US11768198B2 (en) | 2011-02-18 | 2023-09-26 | Bio-Rad Laboratories, Inc. | Compositions and methods for molecular labeling |
US11747327B2 (en) | 2011-02-18 | 2023-09-05 | Bio-Rad Laboratories, Inc. | Compositions and methods for molecular labeling |
US9238206B2 (en) | 2011-05-23 | 2016-01-19 | President And Fellows Of Harvard College | Control of emulsions, including multiple emulsions |
US9573099B2 (en) | 2011-05-23 | 2017-02-21 | President And Fellows Of Harvard College | Control of emulsions, including multiple emulsions |
US8841071B2 (en) | 2011-06-02 | 2014-09-23 | Raindance Technologies, Inc. | Sample multiplexing |
US11754499B2 (en) | 2011-06-02 | 2023-09-12 | Bio-Rad Laboratories, Inc. | Enzyme quantification |
US10195571B2 (en) | 2011-07-06 | 2019-02-05 | President And Fellows Of Harvard College | Multiple emulsions and techniques for the formation of multiple emulsions |
WO2013007028A1 (en) * | 2011-07-14 | 2013-01-17 | 深圳西德赛科技有限公司 | Method and system for self-calibrating microfluidic chip-based detection system |
US11898193B2 (en) | 2011-07-20 | 2024-02-13 | Bio-Rad Laboratories, Inc. | Manipulating droplet size |
US9028776B2 (en) | 2012-04-18 | 2015-05-12 | Toxic Report Llc | Device for stretching a polymer in a fluid sample |
US8685708B2 (en) | 2012-04-18 | 2014-04-01 | Pathogenetix, Inc. | Device for preparing a sample |
US10816550B2 (en) | 2012-10-15 | 2020-10-27 | Nanocellect Biomedical, Inc. | Systems, apparatus, and methods for sorting particles |
US11446665B2 (en) | 2013-03-14 | 2022-09-20 | Cytonome/St, Llc | Hydrodynamic focusing apparatus and methods |
US10583439B2 (en) | 2013-03-14 | 2020-03-10 | Cytonome/St, Llc | Hydrodynamic focusing apparatus and methods |
US11512691B2 (en) | 2013-07-16 | 2022-11-29 | Abs Global, Inc. | Microfluidic chip |
US11187224B2 (en) | 2013-07-16 | 2021-11-30 | Abs Global, Inc. | Microfluidic chip |
US11901041B2 (en) | 2013-10-04 | 2024-02-13 | Bio-Rad Laboratories, Inc. | Digital analysis of nucleic acid modification |
US11796449B2 (en) | 2013-10-30 | 2023-10-24 | Abs Global, Inc. | Microfluidic system and method with focused energy apparatus |
US9588100B2 (en) | 2013-10-30 | 2017-03-07 | Premium Genetics (Uk) Ltd | Microfluidic system and method with focused energy apparatus |
US11639888B2 (en) | 2013-10-30 | 2023-05-02 | Abs Global, Inc. | Microfluidic system and method with focused energy apparatus |
EP3570005A1 (en) * | 2013-10-30 | 2019-11-20 | ABS Global, Inc. | Microfluidic system and method with focused energy apparatus |
US10928298B2 (en) | 2013-10-30 | 2021-02-23 | Abs Global, Inc. | Microfluidic system and method with focused energy apparatus |
US11415503B2 (en) | 2013-10-30 | 2022-08-16 | Abs Global, Inc. | Microfluidic system and method with focused energy apparatus |
US11174509B2 (en) | 2013-12-12 | 2021-11-16 | Bio-Rad Laboratories, Inc. | Distinguishing rare variations in a nucleic acid sequence from a sample |
US11193176B2 (en) | 2013-12-31 | 2021-12-07 | Bio-Rad Laboratories, Inc. | Method for detecting and quantifying latent retroviral RNA species |
US10647981B1 (en) | 2015-09-08 | 2020-05-12 | Bio-Rad Laboratories, Inc. | Nucleic acid library generation methods and compositions |
US11982611B2 (en) | 2017-03-20 | 2024-05-14 | Nanocellect Biomedical, Inc. | Systems, apparatuses, and methods for cell sorting and flow cytometry |
US11331670B2 (en) | 2018-05-23 | 2022-05-17 | Abs Global, Inc. | Systems and methods for particle focusing in microchannels |
US11889830B2 (en) | 2019-04-18 | 2024-02-06 | Abs Global, Inc. | System and process for continuous addition of cryoprotectant |
US11628439B2 (en) | 2020-01-13 | 2023-04-18 | Abs Global, Inc. | Single-sheath microfluidic chip |
Also Published As
Publication number | Publication date |
---|---|
AU770678B2 (en) | 2004-02-26 |
US6506609B1 (en) | 2003-01-14 |
AU5015800A (en) | 2000-12-05 |
CA2373347A1 (en) | 2000-11-23 |
EP1179087B1 (en) | 2019-03-27 |
EP1179087A4 (en) | 2005-12-21 |
EP1179087A1 (en) | 2002-02-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US6506609B1 (en) | Focusing of microparticles in microfluidic systems | |
US6592821B1 (en) | Focusing of microparticles in microfluidic systems | |
US6529835B1 (en) | High throughput methods, systems and apparatus for performing cell based screening assays | |
Basova et al. | Droplet microfluidics in (bio) chemical analysis | |
JP5241678B2 (en) | Microfluidic particle analysis system | |
US20020076825A1 (en) | Integrated biochip system for sample preparation and analysis | |
EP1088229A1 (en) | High throughput methods, systems and apparatus for performing cell based screening assays | |
US20030175980A1 (en) | Ribbon flow cytometry and cell sorting | |
CN107533056A (en) | Acoustics microreactor and its application method | |
NO317958B1 (en) | A microcurrent system for particle separation and analysis | |
JP2005520150A (en) | Ribbon flow cytometry and cell classification | |
US11040347B2 (en) | Microfabricated droplet dispensor with immiscible fluid | |
CA2306138A1 (en) | Method for enhancing fluorescence | |
JP2001502790A (en) | High-throughput screening assay system for micro-scale fluidic devices | |
WO2000056444A2 (en) | Spatially directed interaction on a solid surface | |
CN101548004A (en) | Microfluidic methods for diagnostics and cellular analysis | |
US20180257069A1 (en) | Dynamic microfluidic devices and use thereof | |
WO2021185599A1 (en) | Microfabricated sorter with magnetic sorting stage and droplet dispenser | |
JP5833116B2 (en) | Method and apparatus for analyzing molecular interactions and use of the method and apparatus | |
JP2009133818A (en) | Method and device for feeding liquid in substrate channel | |
US20200129978A1 (en) | Devices and methods for flow control using electro-osmotic flow | |
WO2023177601A1 (en) | Microfabricated droplet dispensor with hydrogel | |
Huang et al. | Advances of Single-Cell Analysis on Microfluidics | |
Dittrich et al. | Cytometry on Microfluidic Chips |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): GH GM KE LS MW SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
ENP | Entry into the national phase |
Ref document number: 2373347 Country of ref document: CA Ref country code: CA Ref document number: 2373347 Kind code of ref document: A Format of ref document f/p: F |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2000932435 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 50158/00 Country of ref document: AU |
|
WWP | Wipo information: published in national office |
Ref document number: 2000932435 Country of ref document: EP |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
NENP | Non-entry into the national phase |
Ref country code: JP |
|
WWG | Wipo information: grant in national office |
Ref document number: 50158/00 Country of ref document: AU |